AeroGrow International 10-K 30 Jun 14 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Mar. 31, 2014	Jun. 20, 2014	Sep. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'AeroGrow International, Inc.	'	'
Document Type	'10-K	'	'
Current Fiscal Year End Date	'--03-31	'	'
Entity Common Stock, Shares Outstanding	'	6,130,026	'
Entity Public Float	'	'	$11,514,510
Amendment Flag	'false	'	'
Entity Central Index Key	'0001316644	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Period End Date	31-Mar-14	'	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'FY	'	'

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Current assets	'	'
Cash and cash equivalents	$1,707	$525
Restricted cash	15	42
Accounts receivable, net of allowance for doubtful accounts of $5 and $1 at March 31, 2014 and 2013, respectively	573	173
Other receivables	187	169
Inventory, net	1,311	1,229
Prepaid expenses and other	306	205
Total current assets	4,099	2,343
Property and equipment, net of accumulated depreciation of $3,024 and $2,869 at March 31, 2014 and 2013, respectively	298	266
Other long-term assets	'	'
Intangible assets, net of accumulated amortization of $0 and $135 at March 31, 2014 and 2013, respectively	2	195
Deposits	145	145
Deferred debt issuance costs, net of accumulated amortization of $278 and $255 at March 31, 2014 and 2013, respectively	0	23
Total other long-term assets	147	363
Total assets	4,544	2,972
Current liabilities	'	'
Accounts payable	553	379
Accrued expenses	306	292
Customer deposits	0	157
Deferred rent	3	6
Notes payable	0	518
Notes payable – related party	0	122
Current portion – long-term debt	0	900
Derivative warrant liability	2,530	0
Debt associated with sale of IP	258	0
Total current liabilities	3,650	2,374
Long-term debt	0	1,169
Total liabilities	3,650	3,543
Commitments and contingencies	'	'
Stockholders' equity (deficit)	'	'
Preferred stock, $.001 par value, 20,000,000 shares authorized, 2,649,007 and 0 issued and outstanding at March 31, 2014 and 2013, respectively	3	0
Common stock, $.001 par value, 750,000,000 shares authorized, 6,129,326 and 5,904,877 shares issued and outstanding at March 31, 2014 and 2013, respectively	6	6
Additional paid-in capital	79,563	75,427
Stock dividend to be distributed	1,456	0
Accumulated (deficit)	-80,134	-76,004
Total stockholders' equity (deficit)	894	-571
Total liabilities and stockholders' equity (deficit)	$4,544	$2,972

BALANCE_SHEETS_Parentheticals

BALANCE SHEETS (Parentheticals) (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, except Share data, unless otherwise specified
Allowance for doubtful accounts (in Dollars)	$5	$1
Accumulated depreciation (in Dollars)	3,024	2,869
Accumulated amortization of intangible assets (in Dollars)	0	135
Accumulated amortization of deferred debt issuance costs (in Dollars)	$278	$255
Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	2,649,007	0
Preferred stock, shares outstanding	2,649,007	0
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized	750,000,000	750,000,000
Common stock, shares issued	6,129,326	5,904,877
Common stock, shares outstanding	6,129,326	5,904,877

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Net revenue	$9,355	$7,330
Cost of revenue	5,582	4,000
Gross profit	3,773	3,330
Operating expenses	'	'
Research and development	95	296
Sales and marketing	2,920	2,325
General and administrative	1,634	1,818
Total operating expenses	4,649	4,439
Loss from operations	-876	-1,109
Other (income) expense, net	'	'
Fair value changes in derivative warrant liability	1,966	0
Interest expense	74	570
Interest expense – related party	8	30
Debt conversion cost	0	6,648
Other (income) expense, net	-518	-98
Total other (income) expense, net	1,530	7,150
Net loss	-2,406	-8,259
Less: Deemed dividend on convertible preferred stock	-268	0
Less: Preferred stock dividend	-1,456	0
Net loss attributable to common shareholders	($4,130)	($8,259)
Net loss per common share, basic and diluted (in Dollars per share)	($0.76)	($1.55)
Weighted average number of common shares outstanding, basic and diluted (in Shares)	5,408	5,344

STATEMENT_OF_CHANGES_IN_STOCKH

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)

Common Stock [Member]

Common Stock [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Stock Dividend to be Distributed [Member]

Retained Earnings [Member]

Stock issued upon conversion of convertible debt [Member]

Conversion of warrants to common stock [Member]

Total

In Thousands, except Share data

Stock issued upon conversion of preferred stock [Member]

USD ($)

Stock issued upon conversion of convertible debt [Member]

Stock issued upon conversion of preferred stock [Member]

Conversion of warrants to common stock [Member]

USD ($)

Stock issued upon conversion of convertible debt [Member]

Stock issued upon conversion of preferred stock [Member]

Conversion of warrants to common stock [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Balances at Mar. 31, 2012

'

'

'

'

'

'

'

'

'

$62,623

'

($67,745)

'

'

($5,122)

Balances (in Shares) at Mar. 31, 2012

'

7,526

'

'

'

210,319

'

'

'

'

'

'

'

'

'

Common stock issued in accordance with Credit Card Notes

'

'

'

'

'

'

'

'

'

177

'

'

'

'

177

Common stock issued in accordance with Credit Card Notes (in Shares)

'

'

'

'

'

141,461

'

'

'

'

'

'

'

'

'

Conversion of convertible securities

'

'

3

1

2

'

10,892

-1

1,559

'

'

'

10,895

1,561

'

Conversion of convertible securities (in Shares)

-7,526

'

2,977,815

950,805

1,624,477

'

'

'

'

'

'

'

'

'

2,977,815

Stock options and restricted stock issued under equity compensation plans

'

'

'

'

'

'

'

'

'

177

'

'

'

'

177

Net (loss)

'

'

'

'

'

'

'

'

'

'

'

-8,259

'

'

-8,259

Balances at Mar. 31, 2013

'

'

'

'

'

6

'

'

'

75,427

'

-76,004

'

'

-571

Balances (in Shares) at Mar. 31, 2013

'

'

'

'

'

5,904,877

'

'

'

'

'

'

'

'

5,904,877

Preferred Stock issued in private placements

'

3

'

'

'

'

'

'

'

3,997

'

'

'

'

4,000

Preferred Stock issued in private placements (in Shares)

'

2,649,007

'

'

'

'

'

'

'

'

'

'

'

'

'

Offering costs in private placement

'

'

'

'

'

'

'

'

'

-828

'

'

'

'

-828

Conversion of convertible securities

'

'

'

'

'

'

'

'

192

'

'

'

'

192

'

Conversion of convertible securities (in Shares)

'

'

'

'

125,000

'

'

'

'

'

'

'

'

'

'

Warrants issued to consultants

'

'

'

'

'

'

'

'

'

144

'

'

'

'

144

Exercise of stock options

'

'

'

'

'

'

'

'

'

106

'

'

'

'

106

Exercise of stock options (in Shares)

'

'

'

'

'

99,449

'

'

'

'

'

'

'

'

'

Stock options and restricted stock issued under equity compensation plans

'

'

'

'

'

'

'

'

'

257

'

'

'

'

257

Deemed dividend on convertible preferred stock

'

'

'

'

'

'

'

'

'

268

'

-268

'

'

'

Stock dividend to be distributed

'

'

'

'

'

'

'

'

'

'

1,456

-1,456

'

'

'

Net (loss)

'

'

'

'

'

'

'

'

'

'

'

-2,406

'

'

-2,406

Balances at Mar. 31, 2014

'

$3

'

'

'

$6

'

'

'

$79,563

$1,456

($80,134)

'

'

$894

Balances (in Shares) at Mar. 31, 2014

'

2,649,007

'

'

'

6,129,326

'

'

'

'

'

'

'

'

6,129,326

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net (loss)	($2,406)	($8,259)
Adjustments to reconcile net (loss) to cash and cash equivalents used by operations:	'	'
Issuance of common stock and options under equity compensation plans	257	177
Issuance of common stock warrants	36	0
Depreciation and amortization expense	156	175
Provision for bad debt	4	3
Fair value remeasurement of derivative warrant liability	1,966	0
Accretion of debt associated with sale of intellectual property	-48	0
Gain on the forgiveness of debt	-489	0
Amortization of debt issuance costs	23	1,044
SMG IP Royalty and Branding License	238	0
Debt conversion costs associated with inducement	0	3,462
Amortization of convertible debentures, beneficial conversion feature	0	1,067
Amortization of convertible debentures, beneficial conversion feature -related party	0	189
Interest expense from warrants issued with convertible debentures	0	954
Interest expense from warrants issued with convertible debentures – related party	0	187
Change in operating assets and liabilities:	'	'
(Increase) decrease in accounts receivable	-404	46
(Increase) decrease in other receivable	-18	28
(Increase) decrease in inventory	-319	290
(Increase) decrease in other current assets	-102	104
Decrease in deposits	0	1
Increase (decrease) in accounts payable	-64	-229
Increase in accrued expenses	15	68
Increase in accrued interest – related party	8	27
Increase in accrued interest	51	175
(Decrease) increase in customer deposits	-157	149
(Decrease) in deferred rent	-3	0
Net cash and cash equivalents provided used by operating activities	-1,256	-342
Cash flows from investing activities:	'	'
Decrease in restricted cash	27	0
Purchases of equipment	-188	-292
Patent expenses	0	-11
Proceeds from the sale of intellectual property	500	0
Net cash and cash equivalents provided (used) by investing activities	339	-303
Cash flows from financing activities:	'	'
Repayment of long term borrowings	-1,356	-396
Proceeds from notes payable, net	0	1,041
Proceeds from notes payable – related party, net	0	245
Repayments of notes payable	-563	-1,031
Repayments of notes payable – related party	-123	-326
Proceeds from exercise of stock options	106	0
Proceeds from issuance of preferred stock	4,000	0
Payments for offering costs of preferred stock	-157	0
Proceeds from the exercise and issuance of warrants	192	1,181
Payments made for debt issuance costs	0	-46
Net cash provided (used) by financing activities	2,099	668
Net increase (decrease) in cash and cash equivalents	1,182	23
Cash and cash equivalents, beginning of period	525	502
Cash and cash equivalents, end of period	1,707	525
Interest paid in cash	43	155
Income taxes paid	0	0
Supplemental disclosure of non-cash investing and financing activities:	'	'
Deemed dividend on convertible preferred stock	268	0
Decrease of inventory associated with debt settlement	237	0
Fair value of derivative warrant liability	564	0
Fair value of warrant issued to preferred stock placement agent	108	0
Debt associated with sale of intellectual property	297	0
Stock dividends accrued on convertible preferred stock	1,456	0
Decrease of debt associated with inventory consumption	0	265
Issuance of common stock in accordance with credit card note	0	177
Conversion of Accrued Expenses to Common Stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	28
Conversion of Note Payable to Common Stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	212
Conversion of Note Payable - Related Party to Common Stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	129
Conversion of Convertible Note to Common Stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	5,718
Conversion of Convertible Note Accrued Interest to Common Stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	545
Conversion of Convertible Note - Related Party to Common Stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	1,079
Conversion of Convertible Note - Related Party Accrued Interest to Common Stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	'	$103

Note_1_Description_of_the_Busi

Note 1 - Description of the Business and Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2014
Disclosure Text Block [Abstract]	'
Basis of Presentation and Significant Accounting Policies [Text Block]	'
	Note 1 – Description of the Business and Summary of Significant Accounting Policies
	Organization and Description of the Business
	AeroGrow International, Inc. (the "Company," “we,” “AeroGrow,” or “our ") was incorporated in the State of Nevada on March 25, 2002.  The Company’s principal business is developing, marketing, and distributing advanced indoor aeroponic garden systems designed and priced to appeal to the consumer gardening, cooking and small indoor appliance markets worldwide.  The Company’s principal activities from its formation through March 2006, consisted of product research and development, market research, business planning, and raising the capital necessary to fund these activities.  In December 2005, the Company commenced pilot production of its AeroGarden system and, in March 2006, began shipping these systems to retail and catalogue customers.  The Company manufactures, distributes and markets seven different models of its AeroGarden systems in multiple colors, as well as over 40 varieties of seed pod kits and a full line of accessory products through multiple channels including retail distribution, catalogue and direct-to-consumer sales in the United States and Canada as well as selected countries in Europe, Asia and Australia.
	Liquidity and Basis of Presentation
	As shown in the accompanying financial statements, we have incurred net losses of $2.4 million and $8.3 million for the years ended March 31, 2014 and 2013, respectively, and have an accumulated deficit of $80.1 million as of March 31, 2014.  As more fully discussed in the Liquidity and Capital Resources section of Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, the Company has developed sources of funding that management believes are sufficient to support the Company’s operating plan for the fiscal year ending March 31, 2015.  The Company’s operating plan is predicated on a variety of assumptions including, but not limited to, the level of customer and consumer demand, the effect of cost reduction programs, and the state of the general economic environment in which the Company operates.  There can be no assurance that these assumptions will prove to be accurate in all material respects, or that the Company will be able to successfully execute its operating plan.
	We may seek additional debt or equity capital during the fiscal year ending March 31, 2015 to address the seasonal nature of our working capital needs, and to enable us to increase the scale of our business.  Sources of funding to meet prospective cash requirements include the Company’s existing cash balances, and cash flow from operations.  There can be no assurance we will be able to raise additional capital.  As part of our efforts to seek additional funding of our operations, in April 2013, we entered into a Securities Purchase Agreement with SMG Growing Media, Inc, a wholly owned subsidiary of Scotts Miracle-Gro Company, a worldwide marketer of branded consumer lawn and garden products (“Scotts Miracle-Gro”).  Pursuant to the Securities Purchase Agreement, Scotts acquired 2,649,007 shares of the Company’s Series B Convertible Preferred Stock and a warrant to purchase shares of the Company’s common stock for an aggregate purchase price of $4.0 million.  (For further information on the strategic alliance with Scotts Miracle-Gro, please see Note 3 “Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions” to our financial statements).
	Significant Accounting Policies
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  It is reasonably possible that a change in the Company’s estimates will occur in the near term and such change could be material.
	Net Income (Loss) per Share of Common Stock
	The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260.  ASC 260 requires companies with complex capital structures to present basic and diluted Earnings per Share (“EPS”).  Basic EPS is measured as the income or loss available to common shareholders divided by the weighted average shares of common stock outstanding for the period.  Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented.  Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.  For the years ended March 31, 2014 and 2013, the Company had 3.6 million (including preferred stock), and 3.5 million, respectively, of securities that could potentially dilute basic EPS in the future that were not included in the computation of diluted EPS because to do so would have been anti-dilutive for the periods presented.
	The following table presents the computation of basic and diluted net income per share for the year ended March 31, 2014 (in thousands, except per share amounts):
		Fiscal Year Ended March 31,
		2014				2013
	Net loss available to common shareholders		$	(4,130	)		(8,259	)
	Basic and diluted:
	Weighted-average shares outstanding			5,408			5,344
	Basic and diluted net loss per share		$	(0.76	)		(1.55	)
	As of March 31, 2014, employee stock options to purchase approximately 397,000 shares of common stock  and  warrants to purchase approximately 575,000 shares of common stock were outstanding but were not included in the computation of diluted net income per share because the effect of including such shares would have been anti-dilutive in the periods presented.
	Reclassifications
	Certain prior year amounts have been reclassified to conform to current year presentation.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.  There were no cash equivalents at March 31, 2014 and 2013.
	Restricted Cash
	The Company has secured activity related to its corporate credit card purchase account with a restricted money market account.  In addition, as discussed in Note 2– Notes Payable and Long Term Debt, 20% of the Company’s daily credit card receipts were held in a restricted escrow account in accordance with the 2011 Credit Card Receipts-Backed Notes which were paid in full during the year ended March 31, 2014.  The balance in this account as of March 31, 2014 and March 31, 2013 was $15,000 and $42,000, respectively.
	Concentrations of Risk
	ASC 825-10-50-20 requires disclosure of significant concentrations of credit risk regardless of the degree of such risk.  Financial instruments with significant credit risk include cash deposits.  The amount on deposit with one financial institution exceeded the $250,000 federally insured limit as of March 31, 2014.  However, management believes that the financial institution is financially sound and the risk of loss is minimal.
	Customers:
	For the years ended March 31, 2014 and 2013, the Company had one customer, Amazon.com, who represented 30.7%, and 10.9%, respectively, of the Company’s net revenue.
	Suppliers:
	For the year ended March 31, 2014, the Company purchased inventories and other inventory related items from four suppliers totaling $1.5 million, $1.4 million, $315,000, and $300,000 representing 26.0%, 24.3%, 5.6% and 5.4% of cost of revenue, respectively.  For the year ended March 31, 2013, the Company purchased inventories and other inventory related items from four suppliers totaling $587,000, $543,000, $469,000, and $360,000 representing 14.6%, 13.5%, 11.7% and 9.0% of cost of revenue, respectively.
	The Company’s primary contract manufacturers are located in China.  As a result, the Company may be subject to political, currency, regulatory, shipping, labor and weather/natural disaster risks.  Although the Company believes alternate sources of manufacturing could be obtained, these risks and any potential loss of supply could have an adverse impact on operations.
	Account Receivables:
	As of March 31, 2014, the Company had three customers, Amazon.com, Costco.com and The Home Depot, that represented 44.1%, 24.5% and 11.1%, respectively, of outstanding accounts receivable.  As of March 31, 2013, the Company had one customer, Amazon.com, that represented 61.2% of outstanding accounts receivable.  Management believes that all receivables from these customers are collectible.
	Fair Value of Financial Instruments
	The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), as it relates to the fair value of its financial assets and liabilities.  This guidance requires disclosure of fair value information about certain financial instruments (insurance contracts, real estate, goodwill and taxes are excluded) for which it is practicable to estimate such values, whether or not these instruments are included in the balance sheet at fair value. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts that could be realized upon immediate liquidation.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability, i.e., exit price, in an orderly transaction between market participants. ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3.  The three levels of the fair value hierarchy are described below:
		Level 1:	Quoted prices (unadjusted) in active markets for identical assets or liabilities.
		Level 2:	Observable market-based inputs, other than quoted prices in active markets for identical assets or liabilities.
		Level 3:	Unobservable inputs.
	The carrying value of financial instruments, including cash, receivables, accounts payable and accrued expenses, approximates their fair value at March 31, 2014 and March 31, 2013 due to the relatively short-term nature of these instruments.  As of March 31, 2014 and March 31, 2013, the fair value of the Company's debt, notes payable, and sale of intellectual property liability, using Level 3 inputs was estimated using the discounted cash flow method, which is based on the future expected cash flows, discounted to their present values, using a discount rate of 15%.
	In conjunction with a Securities Purchase Agreement and strategic alliance with Scotts Miracle-Gro on April 22, 2013, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock together with existing stock owned.  This warrant was accounted for as a liability at its estimated fair value and is classified as a Level 3 fair value measurement.  The Company calculated the fair value of the warrant during the fiscal year ended March 31, 2014 using Level 3 inputs in a Monte Carlo simulation model.  As of March 31, 2014, the Company measured the warrant at fair value and will continue to do so on a quarterly basis.  As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.
			31-Mar-14						31-Mar-13
	(in thousands)		Fair Value			Carry Value			Fair Value		Carry Value
	Liabilities
	Notes payable		$	-		$	-		$	610	$	641
	Sale of intellectual property liability			171			258			-		-
	Derivative warrant liability			2,530			2,530			-		-
	Long-term debt			-			-			1,726		2,068
	Total		$	2,701		$	2,788		$	2,336	$	2,709
	Property and Equipment
	Property and equipment are stated at cost.  Depreciation for financial accounting purposes is computed using the straight-line method over the estimated lives of the respective assets.  Office equipment and computer hardware are depreciated over five years.  Tooling is depreciated over three years. Leasehold improvements are being amortized over the life of the lease.
	Property and equipment consist of the following:
			March 31,			March 31,
	(in thousands)		2014			2013
	Manufacturing equipment and tooling		$	2,423		$	2,269
	Computer equipment and software			435			406
	Leasehold improvements			116			112
	Other equipment			348			348
				3,322			3,135
	Less:  accumulated depreciation			(3,024	)		(2,869	)
	Property and equipment, net		$	298		$	266
	Depreciation expense for the years ended March 31, 2014 and 2013, was $156,000, and $161,000, respectively.
Intangible Assets
Intangible assets consist of the direct costs incurred for application fees and legal expenses associated with patents and trademarks on the Company's products.  The Company periodically reviews the value of the intangible assets.  To the extent carrying values exceed estimated fair values, the Company records a reduction in the carrying value to the determined fair value.   The Company amortizes its patent and trademark costs on a straight line basis over their estimated useful life of 17 years.
Intangible assets consist of the following:
		March 31,			March 31,
(in thousands)		2014			2013
Patents		$	-		$	286
Trademarks			2			44
			2			330
Less:  accumulated amortization			-			(135	)
Intangible assets, net		$	2		$	195
Amortization expense for the years ended March 31, 2014 and 2013, was less than $1,000 and $14,000, respectively.
As of April 22, 2013, the Company agreed to sell to Scotts Miracle-Gro all intellectual property associated with the Company’s hydroponic products, other than the AeroGrow and AeroGarden trademarks, free and clear of all encumbrances, for $500,000.  Scotts Miracle-Gro has the right to use the AeroGrow and AeroGarden trademarks in connection with the sale of products incorporating the Hydroponic IP.
In return, Scotts Miracle-Gro granted the Company an exclusive right to use the Hydroponic intellectual property (“IP”) in North America and certain European countries in return for a royalty of 2% of annual net sales, as determined at the end of each fiscal year.  The royalty is payable in the Company's common stock at the conversion price of the Series B Preferred Stock (see Note 3).  The initial term of the Technology License is five years, and the Company may renew the Technology License for an additional five-year term by providing notice to Scotts Miracle-Gro at least six months in advance of the expiration of each five-year term.  Please see Note 3 “Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions” to our financial statements for further discussion.
Inventory
Inventories are valued at the lower of cost, as determined by the first-in, first-out method, or market. Included in inventory where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity.  A majority of the Company’s products are manufactured overseas and are recorded at standard cost.
		March 31,			March 31,
(in thousands)		2014			2013
Finished goods		$	784		$	606
Raw materials			527			623
		$	1,311		$	1,229
The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product.  As of March 31, 2014 and 2013, the Company had reserved $332,000 and $94,000, respectively, for inventory obsolescence.
Accounts Receivable and Allowance for Doubtful Accounts
The Company sells its products to retailers and consumers. Consumer transactions are paid primarily by credit card. Retailer sales terms vary by customer, but are generally net 30 days to net 60 days. Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable.  The Company's allowance estimate is based on a review of the current status of trade accounts receivable.
Other Receivables
In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for required credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor.  This reserve is equal to 5% of the credit card sales processed during the previous six months. As of March 31, 2014 and March 31, 2013, the balance in this reserve account was $187,000 and $169,000, respectively.
Advertising and Production Costs
The Company expenses all production costs related to advertising, including, print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed.  The Company records media costs related to its direct-to-consumer advertisements, inclusive of postage and printing costs incurred in conjunction with mailings of direct response catalogues, and related direct response advertising costs, in accordance ASC 340-20-Reporting on Advertising Costs.  As prescribed by ASC 340-20-25, direct-to-consumer advertising costs incurred should be reported as assets and should be amortized over the estimated period of the benefits, based on the proportion of current period revenue from the advertisement to probable future revenue.
As the Company has re-entered the retail distribution channel, the Company has expanded its advertising to online gateway and portal advertising, as well as placement in third party catalogues.
Advertising expenses for the years ended March 31, 2014 and March 31, 2013, were as follows:
		Fiscal Year Ended March 31,
		2014			2013
(in thousands)
Direct-to-consumer		$	786		$	1,055
Retail			404			1
Total advertising expense		$	1,190		$	1,056
As of March 31, 2014 and March 31, 2013, the Company had deferred $16,000 and $4,000, respectively, related to such media costs.  The costs are included in the prepaid and other expenses line of the balance sheet.
Research and Development
Research, development, and engineering costs are expensed as incurred.  Research, development, and engineering expenses primarily include payroll and headcount related costs, contractor fees, infrastructure costs, and administrative expenses directly related to research and development support.
Stock-Based Compensation
The Company uses the Black-Scholes option valuation model to estimate the fair value of stock option awards.  For the years ended March 31, 2014 and March 31, 2013, equity compensation in the form of stock options and grants of restricted stock that vested totaled $257,000 and $177,000, respectively, and is included in the accompanying Statements of Operations in the following categories:
		Years ended
(in thousands)		31-Mar-14			31-Mar-13
General and administrative		$	200		$	136
Sales and marketing			57			41
Total		$	257		$	177
Income Taxes
Deferred income taxes are recognized for the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at the end of each period, based on enacted laws and statutory rates applicable to the periods in which the differences are expected to affect taxable income.  Any liability for actual taxes to taxing authorities is recorded as income tax liability. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.  A valuation allowance is established against such assets where management is unable to conclude that it is “more likely than not” that the value of such asset will be realized.  As of March 31, 2014 and March 31, 2013, the Company recognized a valuation allowance equal to 100% of the net deferred tax asset balance.
Revenue Recognition
The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists: that is, a product is shipped under an agreement with a customer; risk of loss and title has passed to the customer; the fee is fixed or determinable; and collection of the resulting receivable is reasonably assured.
The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions and other volume-based incentives. Certain incentive programs require the Company to estimate based on industry experience the number of customers who will actually redeem the incentive.  At March 31, 2014 and March 31, 2013, the Company had accrued $42,000 and $43,000 respectively, as its estimate for the foregoing deductions and allowances.  These expenses are included in the accrued expenses line of the balance sheet.
Warranty and Return Reserves
The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program.  The specific warranty terms and conditions vary depending upon the product sold but generally include technical support, repair parts and labor for periods up to one year.  Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation.   Based upon the foregoing, the Company has recorded as of March 31, 2014 and March 31, 2013 a provision for potential future warranty costs of $11,000 and $10,000, respectively.  These warranty expenses are included in the accrued expenses line of the balance sheet.
The Company reserves for known and potential returns and associated refunds or credits related to such returns based upon historical experience. In certain cases, customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments to us by such customers.  As of March 31, 2014 and March 31, 2013, the Company has recorded a reserve for customer returns of $61,000 and $27,000, respectively.  These expenses are included in the accrued expenses line of the balance sheet.
Shipping and Handling Costs
Shipping and handling costs associated with inbound freight are recorded in cost of revenue. Shipping and handling costs associated with freight out to customers are also included in cost of revenue. Shipping and handling charges paid by customers are included in product sales.
Deferred Rent
In July 2006, the Company entered into a facility lease with a term through January 2012, for its corporate offices in Boulder, Colorado.  As of September 30, 2011 this lease was extended through September 30, 2014.  As of April 14, 2014 the lease term was extended to September 30, 2016.  As of March 31, 2014 and March 31, 2013, the Company had recorded deferred rent related to this agreement in the amount of $3,000 and $6,000, respectively, based on the difference between straight-line rent expense recorded and the rent payment obligation.
Deferred Debt Issuance Costs
The Company capitalizes debt issuance costs that are directly attributable to realizing the proceeds of the debt issued and it is amortized over the contractual life of the debt using the effective interest rate method.
Segments of an Enterprise and Related Information
GAAP utilizes a management approach based on allocating resources and assessing performance as the source of the Company's reportable segments.  GAAP also requires disclosures about products and services, geographic areas and major customers.  At present, the Company operates in one segment.
New Accounting Pronouncements
In July 2013, the FASB issued ASU 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” which among other things, requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as denoted within the ASU.  The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013.  This new guidance will not have a material impact on our financial statements.
In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers," which amended revenue recognition guidance to clarify the principles for recognizing revenue from contracts with customers.  The guidance requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services.  The guidance also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract.   This accounting guidance is effective for the Company beginning in the first quarter of fiscal year 2018 using one of two prescribed retrospective methods.  Early adoption is not permitted.  We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.

Note_2_Notes_Payable_and_Long_

Note 2 - Notes Payable and Long Term Debt	12 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	Note 2 – Notes Payable and Long Term Debt
	We relied upon a variety of debt funding sources to help meet our liquidity requirements during the fiscal years ended March 31, 2014 and 2013, as summarized below:
		March 31,		March 31,
		2014		2013
		(in thousands)		(in thousands)
	Main Power Promissory Note	$	-	$	1,704
	First Western Trust Term Loan		-		323
	Notes Payable –Credit Card Receipts-Backed Notes		-		640
	Pawnee Lease Promissory Note		-		42
	Sale of intellectual property liability (see Note 3)		258		-
	Derivative warrant liability (see Note 3)		2,530		-
	Total debt		2,788		2,709
	Less current portion		2,788		1,540
	Long term debt	$	-	$	1,169
	Main Power Promissory Note
	On June 30, 2009, the Company entered into a Letter Agreement (“Letter Agreement”) with Main Power Electrical Factory, Ltd. (“Main Power”) and executed a Promissory Note.  Pursuant to the terms of the Letter Agreement, Main Power agreed to release AeroGrow from $1.4 million of existing obligations owed to Main Power in return for the execution of the Promissory Note for the same amount.  In addition, the Letter Agreement included other provisions relating to the terms and conditions under which the Company purchase AeroGarden products from Main Power.
	Effective as of December 31, 2010 and again as of December 31, 2011, AeroGrow and Main Power entered into an agreement to amend various obligations owed by AeroGrow to Main Power, restructured the amortization schedule for the Main Power Note and ultimately extended the final maturity to December 15, 2015.  In addition, Main Power agreed to waive any existing defaults under the Revised Main Power Note.  The agreed revisions to the amortization schedule provided for monthly interest payments through the final maturity and principal payments totaling $159,000 during Fiscal 2013, $555,000 during the fiscal year ending March 31, 2014, $725,000 during the fiscal year ending March 31, 2015, and $665,000 during the period April 2015 through December 2015.   On April 23, 2013, we repaid the Main Power Promissory Note in full, including the principal balance and all accrued interest, for $950,000, resulting in a net gain of approximately $489,000.  For further information in the termination of the Main Power Promissory Note, please see Note 3 “Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions” to our financial statements.
	First Western Trust Term Loan
	On May 21, 2010, the Company, First Western Trust Bank (“FWTB”) and Jack J. Walker, our Chairman, as guarantor, executed a business loan agreement and related promissory note (the “FWTB Term Loan”) for a four-year loan in an initial principal amount of $1 million.  The FWTB Term Loan was secured by a lien on our assets.  The FWTB Term Loan bore interest at a fixed rate of 7.25% per annum.  We made equal monthly payments of principal/interest on the FWTB Term Loan, which had a final maturity date of May 21, 2014.   However, as of March 21, 2014, we repaid the FWTB Loan in full including the principal balance and all accrued interest.
	Subordinated Secured Convertible Notes
	Between May and September 2010, we completed a private offering of $7.0 million in Subordinated Secured Convertible Notes (the “Subordinated Secured Convertible Notes”) and warrants to purchase 70,200 shares of our common stock (the “Warrants”).  The Company used the proceeds from the private offering to invest in advertising and marketing programs to support our direct-to-consumer business, provide general working capital, pay commissions and expenses related to the private offering, and repay certain outstanding obligations.
	On April 11, 2012, Subordinated Secured Convertible Notes totaling $7.4 million, inclusive of accrued interest of $648,000, were converted into 2,977,815 shares of our common stock, reflecting a conversion price of $2.50 per share of common stock.   The Subordinated Secured Convertible Note holders agreed to convert the Subordinated Secured Convertible Notes into common stock in exchange for our agreement to reduce the conversion price from $10.00 per share of common stock to $2.50 per share of common stock.  As a result of the conversion of the Subordinated Secured Convertible Notes into common equity, the Company recognized a total of $6.6 million in non-cash expense, comprising $3.4 million of debt conversion costs on the exchange and $3.2 million on the accelerated recognition of the debt discount and deferred debt issuance costs during Fiscal 2013.
	As of March  31, 2013, there were no Subordinated Secured Convertible Notes or accrued interest outstanding.
	Notes Payable – 2011 Credit Card Receipts-Backed Notes
	During the three months ended December 31, 2011, the Company closed on the private sale of $1.6 million in 17% secured promissory notes backed by a portion of our prospective credit card receipts, (the “2011 Credit Card Notes”) and a 1% share of our prospective monthly sales into the network marketing channel for a period of three years following our first sale into the network marketing channel (the “MLM Revenue Share”) (collectively, the “2011 Credit Card Offering”).  Consideration for the 2011 Credit Card Offering consisted of $1.5 million in cash and the conversion of $156,000 in other obligations of the Company, including $61,000 of deferred compensation owed to executive officers of AeroGrow.  After deducting $47,000 of placement agent sales commissions and expenses, net cash proceeds to AeroGrow totaled $1.4 million.  In addition, the Company paid a deferred sales commission to the placement agent equal to 10% of the MLM Revenue Share paid to investors in the 2011 Credit Card Offering (with the deferred sales commission reduced to 6% for payments to company-referred investors and 0% on payments to officers and directors), concurrently with the payment of the MLM Revenue Share.  The Company used the proceeds from the 2011 Credit Card Offering to invest in advertising and marketing programs to support our direct-to-consumer business, purchase inventory, provide other general working capital, and pay commissions and expenses related to the private offering.
	For the years ended March 31, 2014 and March 31, 2013, the total amortized deferred debt issuance costs relating to the 2011 Credit Card Offering were $0 and $218,000, respectively.
	As of September 13, 2012, the Company repaid the remaining principal balance and accrued interest on the 2011 Credit Card Notes in full.
	Notes Payable – 2012 Credit Card Receipts-Backed Notes
	On September 14, 2012, the Company closed on the private sale of $1.3 million in Series 2012CC 15% secured promissory notes backed by a portion of our prospective credit card receipts, (the “2012 Credit Card Notes”) and 128,573 shares of common stock (collectively, the “2012 Credit Card Offering”).  Consideration for the 2012 Credit Card Offering comprised $1.3 million in cash.  After deducting $47,000 of placement agent sales commissions (5% on third-party investors, 3% on company-referred investors and 0% on investments by our officers and directors) and expenses, net cash proceeds to AeroGrow totaled $1.2 million.  In addition, the Company issued 12,858 shares of common stock to the placement agent as additional sales compensation, representing one share of common stock for every 10 shares issued to investors in the 2012 Credit Card Offering.
	The Company used the proceeds from the 2012 Credit Card Offering to invest in advertising and marketing programs to support its direct-to-consumer business, purchase inventory, provide other general working capital, repay $198,000 of the 2011 Credit Card Notes (including accrued interest) and pay commissions and expenses related to the private offering.   Our directors and officers invested $245,000 in the 2012 Credit Card Offering and were issued 2012 Credit Card Notes with a face amount of $245,000 and 24,500 shares of common stock.  Investors having a beneficial ownership in AeroGrow of more than 5% who are not also directors or officers invested $350,000 in the 2012 Credit Card Offering and were issued 2012 Credit Card Notes with a face amount of $350,000 and 35,000 shares of common stock.  The investments by the directors, officers, and investors having a beneficial ownership in AeroGrow of more than 5% were on the same terms and conditions as all other investors in the 2012 Credit Card Offering.
	The 2012 Credit Card Notes bore interest at 15% per annum and had a final maturity of November 1, 2013.  As of October 30, 2013, the 2012 Credit Card Notes final maturity was extended to January 31, 2014, by all the investors.  20% of our daily credit card receipts were held in escrow with First Western Trust Bank under an Escrow and Account Control Agreement to fund bi-weekly payments of principal and interest to the investors in the 2012 Credit Card Offering.
	However, on December 17, 2013, the Company repaid the 2012 Credit Card Notes in full, including the principal balance and accrued interest.
	For the year ended March 31, 2014 and March 31, 2013, the total amortized deferred debt issuance costs relating to the 2012 Credit Card Offering was $23,000 and $24,000, respectively.
	Pawnee Lease Promissory Note
	On November 30, 2011, the Company executed a promissory note (the “Lease Promissory Note”) in the principal amount of $116,000 in favor of Pawnee Properties, LLC (“Pawnee”).  The Lease Promissory Note detailed the terms and conditions pursuant to which the Company will pay to Pawnee past due rent and building operating expenses related to our headquarters lease.  The Lease Promissory Note carried an interest rate of 6% per annum for the first twelve months, and 8% per annum thereafter.  As of February 24, 2014, the outstanding balance of the Lease Promissory Note, including accrued interest, was repaid in full.
	Debt Payment Obligations
	As of the fiscal year ended March 31, 2014, we have no debt due requiring any cash payments.  The debt in the current liability is related to the Scotts Miracle-Gro transaction, for further information see Note 3 to our financial statements.
	Liability Associated with Scotts Miracle-Gro Transaction
	On April 22, 2013, the Company issued Series B Convertible Preferred Stock to a wholly-owned subsidiary of Scotts Miracle-Gro.  Pursuant to U.S. GAAP, the Company has classified the warrant as a liability at its estimated fair value.  The derivative warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period until it is exercised or expires.  The valuation techniques used to determine the fair value of the derivative warrant liability and the terms of the warrant are further explained in Note 3.  As of March 31, 2014 the fair value of the warrant was $2.5 million.
	The Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues. Since the Company received cash from Scotts Miracle-Gro and agreed to pay for a defined period a specified percentage of revenue, and because the Company has significant involvement in the generation of its revenue, the excess paid over net book value is classified as a liability and is being amortized under the effective interest method.  As of March 31, 2014, $258,000 was recorded as a liability on the condensed balance sheets.

Note_3_Scotts_MiracleGro_Trans

Note 3 - Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions	12 Months Ended
	Mar. 31, 2014
Convertible Preferred Stock Warrants And Other Transactions [Abstract]	'
Convertible Preferred Stock Warrants And Other Transactions [Text Block]	'
	Note 3 – Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions
	On April 22, 2013, the Company entered into a Securities Purchase Agreement with SMG Growing Media, Inc. (the “Investor”), a wholly owned subsidiary of Scotts Miracle-Gro (NYSE: “SMG”), a worldwide marketer of branded consumer lawn and garden products.  Pursuant to the Securities Purchase Agreement, Scotts Miracle-Gro acquired 2,649,007 shares of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”), and (ii) a warrant to purchase shares of the Company’s common stock (the “Warrant,” as described in greater detail below) for an aggregate purchase price of $4.0 million.  The Securities Purchase Agreement, Certificates of Designations for the Series B Preferred Stock, Form of Warrant, Indemnification Agreement, Investor’s Rights Agreement and Voting Agreement have been filed as exhibits to a Current Report on Form 8-K that was filed with the SEC on April 23, 2013.  After deducting offering expenses, including commissions and expenses paid to the Company’s advisor, net cash proceeds to the Company totaled to $3.8 million.  The Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Promissory Note due to Main Power (Note 2).  Main Power also released the Company’s pledged collateral and the parties agreed to terminate the Letter Agreement and Promissory Note effective as of April 22, 2013, as further described in Note 2.  The Company did not incur any early termination penalties.  As of April 23, 2013, there was $237,000 in consignment inventory held by Main Power that was fully reserved for during the three-month period ended June 30, 2013.  The Company plans to use the remaining net proceeds for working capital and general corporate purposes.
	The Company also issued a warrant to purchase 125,000 shares of the Company’s common stock to the placement agent.  This warrant has an exercise price of $1.54 per share (125% of the average closing price of the Company’s common stock during the five-day period prior to the April 22, 2013 closing date).  The value of this warrant was estimated at $108,000, based on the Black-Scholes model with a stock price of $1.30, calculated exercise price of $1.54, expected life of three years, annualized volatility of 117.2% and a discount rate of 0.39%.  The value of the warrant was recorded as stock issuance costs.
	The Series B Preferred Stock is convertible into 2,649,007 shares of common stock ($4.0 million divided by a conversion price of $1.51 per share).  The Series B Preferred Stock bears a cumulative annual dividend of 8.0%, payable in shares of the Company’s common stock at a conversion price of $1.51 per share (subject to customary anti-dilution rights, as described in the Series B Preferred Stock Certificates of Designations).  The Series B Preferred Stock does not have a liquidation preference and is entitled to vote on an “as-converted” basis with the common stock.  The Series B Preferred Stock automatically converts into the Company’s common stock: (i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Preferred Stock own 50.1% of the issued and then-outstanding common stock of the Company, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Preferred Stock and such exercise of the Warrant.
	The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a “fully diluted basis” (as defined in the Securities Purchase Agreement), constitute 80% of the Company’s outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise.  The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date).  In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time.  The exercise price of the Warrant shall be equal to the quotient obtained by dividing:
	(a) an amount equal to (i) 1.34 times the trailing twelve months “Net Sales” (which includes sales of the Company’s products by Scotts Miracle-Gro and its affiliates) minus (ii) “Debt Outstanding” net of cash (as such terms are defined in the Warrant,
	by
	(b) the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.
	The Warrant expires on April 22, 2021, the eighth anniversary of the closing date.  The Warrant contains customary anti-dilution rights (for stock splits, stock dividends and sales of substantially all the Company’s assets).  Scotts Miracle-Gro also has the right to participate pro rata, based on Scotts Miracle-Gro’s percentage equity ownership in the Company (assuming the exercise of Scotts Miracle-Gro’s Warrant, but not the exercise of any options outstanding under the Company’s equity compensation plans) in future issuance of equity securities by the Company.  Upon exercise of the Warrants and demand by Scotts Miracle-Gro, the Company must use its best efforts to file a Registration Statement on Form S-3, or, if the Company is not eligible for Form S-3, on Form S-1 (collectively, the “Registration Statement”), covering the shares of the Company’s common stock covered by the Preferred Stock and the Warrant, within 120 calendar days after receipt of Scotts Miracle-Gro’s demand for registration and shall use its best efforts to cause the Registration Statement to become effective as soon as possible thereafter.
	The Private Offering and sale of the Series B Preferred Stock and Warrant was conducted in reliance upon exemptions from registration requirements under the Securities Act, including, without limitation, those under Regulation D promulgated under the Securities Act.  Scotts Miracle-Gro is an “accredited investor,” as defined in Rule 501 of Regulation D under the Securities Act.  Because the Series B Preferred Stock and the Warrant have not been registered under the Securities Act, they may not be reoffered or resold in the United States absent registration or an applicable exemption from registration.
	Under the Securities Purchase Agreement, the Company’s Board of Directors (the “Board”) is required to consist of five members, which shall be set forth in the Company’s Bylaws.  In addition, Scotts Miracle-Gro is entitled to appoint one member to the Board and have one additional Board observer while the Warrant remains outstanding, pursuant to provision, Scotts Miracle-Gro has appointed Chris J. Hagedorn to the Company’s Board effective as of April 22, 2013.
	The foregoing description of the Securities Purchase Agreement, the Certificates of Designations for the Series B Preferred Stock, the Warrant, and the resulting transaction is only a summary, does not purport to be complete, and is qualified in its entirety by reference to the full text of the applicable documents, each of which was included as an exhibit to the Company’s Current Report on Form 8-K, as filed with the SEC on April 23, 2013.  The warrant on the Series B Convertible Preferred Stock was accounted for as a liability at its estimated fair value of $2.5 million as of March 31, 2014.  The warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period until it is exercised or expires.  The Company calculated the fair value of the warrant during the quarter ended March 31, 2014 using a Monte Carlo simulation model.
	In conjunction with the Private Offering described above, the Company and Scotts Miracle-Gro also agreed to the following:
	Intellectual Property Sale.  The Company also agreed to sell to Scotts Miracle-Gro all intellectual property associated with the Company’s hydroponic products (the “Hydroponic IP”), other than the AeroGrow and AeroGarden trademarks, free and clear of all encumbrances, for $500,000.  Scotts Miracle-Gro has the right to use the AeroGrow and AeroGarden trademarks in connection with the sale of products incorporating the Hydroponic IP.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues.  Since the Company received cash from Scotts Miracle-Gro and agreed to pay for a defined period a specified percentage of the revenue, and the Company has significant involvement in the generation of the revenue, the excess paid over net book value is classified as a liability and is being amortized under the effective interest method.  As of March 31, 2014, $258,000 was recorded as a liability on the condensed balance sheets.
	Technology Licensing Agreement.  The Company was granted an exclusive license (the “Technology License”) to use the Hydroponic IP in North America and certain European countries (collectively, the “Company Markets”) in return for a royalty of 2% of annual net sales (the “Royalty”), as determined at the end of each fiscal year.  The Royalty is payable in the Company's common stock at the conversion price of the Series B Preferred Stock.  As of March 31, 2014, the Company has accrued $187,000 for the Technology Licensing Agreement.  The initial term of the Technology License is five years, and the Company may renew the Technology License for an additional five-year terms by providing notice to Scotts Miracle-Gro at least six months in advance of the expiration of each five-year term, provided that Scotts Miracle-Gro is not in default under the Technology Licensing Agreement at the time of renewal.  The Technology License may not be assigned.
	Brand License.  The Company and Scotts Miracle-Gro also entered a brand license whereby the Company may use certain of Scotts Miracle-Gro’s trade name, trademark and/or service mark to rebrand the AeroGarden and, with the written consent of Scotts Miracle-Gro, other products in the Company Markets in exchange for the Company’s payment to Scotts Miracle-Gro of an amount equal to 5% of incremental growth in annual net sales, as compared to net sales during the fiscal year ended March 31, 2013.  Such brand license compensation is payable in the Company’s common stock at $1.51 per share (the conversion price of the Series B Preferred Stock).  The initial term of the brand license will be five years, and the Company may renew the license for additional five-year terms by providing notice to Scotts Miracle-Gro at least six months in advance of the expiration of each five-year term, provided that Scotts Miracle-Gro is not in default under the brand license at the time of renewal.  The brand license may not be assigned.  The brand license may only be terminated by Scotts Miracle-Gro in the event of an uncured default, under the terms of the brand license.
	Collaboration.  During the term of the Brand License, the Company has access to Scotts Miracle-Gro’s business development team, selling, marketing and supply chain resources, customer and email lists, for reasonable “out of pocket” costs, and Scotts Miracle-Gro will have access to the Company’s consumer email lists.
	Supply Chain Services Agreement.  During the term of the Technology License Agreement, Scotts Miracle-Gro will pay the Company an annual fee equal to 7% of the cost of goods of all products that Scotts Miracle-Gro purchases from the Company or a vendor, in exploiting the hydroponic IP internationally (outside of the Company Markets) over the course of each contract year during the term of the Securities Purchase Agreement.

Note_4_Equity_Compensation_Pla

Note 4 - Equity Compensation Plans	12 Months Ended
	Mar. 31, 2014
Share-based Arrangements with Employees and Nonemployees [Abstract]	'
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	'
	Note 4 – Equity Compensation Plans
	In August 2005, the Company’s Board of Directors approved the 2005 Equity Compensation Plan (the “2005 Plan”) pursuant to which both qualified and nonqualified stock options as well as restricted shares of common stock are reserved for issuance to eligible employees, consultants and directors of the Company.  A total of 13,505,000 shares of our common stock may be granted under the 2005 Plan as the original 1,505,000 was increased by 2,000,000 shares on October 1, 2008 and 10,000,000 shares on July 25, 2010.  On October 17, 2012, a 1-for-100 reverse stock split of AeroGrow’s common stock became effective.  As a result of the reverse stock split, every 100 shares of AeroGrow’s “pre-reverse split” common stock were converted automatically into one share of common stock.  All references below to shares of common stock, common stock warrants, or common stock options have been adjusted to reflect the reverse stock split.
	The 2005 Plan is administered by the Company’s Governance, Compensation and Nominating Committee, which has the authority to select the individuals to whom awards are to be granted, the number of shares of common stock to be covered by each award, the vesting schedule of stock options and/or restricted stock,, and all other terms and conditions of each award.  The Company has granted qualified stock options to purchase shares of common stock to certain employees at exercise prices ranging from $1.01 to $20.00 per share.
	For the years ended March 31, 2014 and March 31, 2013, respectively, the Company granted to employees 331,000, and 266,000 options to purchase the Company’s common stock under the 2005 Plan.  All the options granted during the fiscal year ended March 31, 2014 had an exercise price ranging from $1.10 to $2.42 per share.  As of March 31, 2014, the Company had a total of 397,000 options outstanding with exercise prices ranging from $1.01 to $13.00 per share.  Please refer to the table below.
	For the options granted on February 8, 2013, the Company used the following weighted average assumptions:  no dividend yield; expected volatility rates of 116.06%; risk free interest rates of 0.4%, and average life of three years resulting in a value of $0.69 per share granted under the option agreement based on the market value on the date of grant.
	For the options granted on April 1, 2013, the Company used the following weighted average assumptions:  no dividend yield; expected volatility rates of 117.21%; risk free interest rates of 0.39%, and average life of three years resulting in a value of $0.76 per share granted under the option agreement based on the market value on the date of grant.  For the options granted on October 9, 2013, the Company used the following weighted average assumptions:  no dividend yield; expected volatility rates of 118.29%; risk free interest rates of 0.62%, and average life of three years resulting in a value of $1.53 per share granted under the option agreement based on the market value on the date of grant.  As a result of recognizing compensation expense for stock options, the net loss for the years ended March 31, 2014 and March 31, 2013, was increased by $257,000 and $177,000, respectively.
	A summary of option activity in the 2005 Plan is as follows:
							Exercise price
			Options												Weighted-
			(in thousands)				Low				High				Average
	Balances at April 1, 2012			106			$	7			$	20			$	9.5
	Granted			266				1.01				1.01				1.01
	Exercised			-				-				-				-
	Forfeited			(92	)			1.01				12				1.39
	Balances at March 31, 2013			280				1.01				20				4.11
	Granted			331				1.1				2.42				1.89
	Exercised			(100	)			1.01				2.2				1.09
	Forfeited			(114	)			1.01				20				5.08
	Balances at March 31, 2014			397			$	1.01			$	13			$	1.63
	Information regarding all stock options outstanding under the 2005 Plan as of March 31, 2014 is as follows:
					OPTIONS OUTSTANDING														OPTIONS EXERCISABLE
									Weighted-												Weighted-
									average								Aggregate				average		Weighted-		Aggregate
									Remaining				Weighted-				Intrinsic				Remaining		average		Intrinsic
	Exercise price				Options (in thousands)				Contractual Life (years)				Exercise Price				Value (in thousands)		Options (in thousands)		Contractual Life (years)		Exercise Price		Value (in thousands)
	$	1.01				106				3.86			$	1.01						38		3.86	$	1.01
	$	1.1				60				4			$	1.1						60		4	$	1.1
	$	1.21				50				4			$	1.21						50		4	$	1.21
	$	2.2				169				4.41			$	2.2						51		4.16	$	2.2
	$	2.42				10				4.52			$	2.42						5		4.52	$	2.42
	$	7				-				0.27			$	7						-		0.27	$	7
	$	12				1				0.44			$	12						1		0.44	$	12
	$	13				1				0.36			$	13						1		0.36	$	13
						397				4.14			$	1.63			$	2,260		206		4	$	1.49	$	1,206
	The aggregate intrinsic value in the preceding table represents the difference between the Company’s closing stock price and the exercise price of each in-the-money option on the last trading day of the period presented.
	At March 31, 2014, there are unvested outstanding options to purchase 191,000 shares of the Company’s common stock that will result in $235,000 of compensation expense as they vest over the next 18 months.

Note_5_Income_Taxes

Note 5 - Income Taxes	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	Note 5 – Income Taxes
	Under the provisions of GAAP, a deferred tax asset or liability (net of a valuation allowance) is provided in the financial statements by applying the provisions of applicable laws to measure the deferred tax consequences of temporary differences that will result in taxable or deductible amounts in future years as a result of events recognized in the financial statements in the current or preceding years.
	Income tax provision consisted of the following:
	(in thousands)
		For the Years Ended March 31,
		2014			2013
	Current:
	Federal	$	-		$	-
	Foreign
	State		2			1
			2			1
	Deferred:
	Federal		-			-
	Foreign		-			-
	State		-			-
			-			-
	Income tax provision	$	2		$	1
	Reconciliation of effective tax rate:
		For the Years Ended March 31,
		2014			2013
	Federal taxes at statutory rate		34	%		34	%
	State taxes, net of federal benefit		0.21	%		1.18	%
	Permanent items		-31.27	%		-15	%
	Change in effective tax rate		9.02	%		-4.14	%
	Prior year adjustment to book income		0	%		0	%
	Other Adjustments		-0.8	%		0.14	%
	Valuation allowance		-8.85	%		-16.19	%
	Stock-based compensation		-2.36	%		0	%
	Effective income tax rate		-0.05	%		-0.02	%
	(in thousands)	As of March 31,
		2014			2013
	Deferred tax assets:
	Net Operating Loss	$	21,885		$	21,566
	R & D credit carryforwards		597			603
	Intangibles and fixed assets		152			110
	Accrued compensation		20			3
	Allowance for bad debt		2			-
	Reserve for customer returns		22			10
	Warranty reserve		4			3
	Reserve for obsolete inventory		122			34
	Stock-compensation		1,412			1,483
	Charitable contributions		2			3
	Other		34			76
	Gross deferred tax assets		24,252			23,891
	Deferred tax liabilities:
	Prepaid expenses		(64	)		(44	)
	Gross deferred tax liabilities		(64	)		(44	)
	Net deferred tax assets before valuation allowance		24,188			23,847
	Valuation allowance		(24,188	)		(23,847	)
	Deferred tax assets (liabilities), net	$	-		$	-
	The Tax Reform Act of 1986 contains provisions that limit the utilization of net operating loss and tax credit carryforwards if there has been a change of ownership as described in Section 382 of the Internal Revenue Code.  The Company has not prepared an analysis to determine if a change of ownership has occurred.  Such a change of ownership may limit the Company's utilization of its net operating losses.
	At March 31, 2014 and March 31, 2013, respectively, approximately $60.2 million and $60.3 million of net operating loss carryforwards for federal income tax purposes were available to offset future taxable income through the year 2034.  As of March 31, 2014, approximately $546,000 of the net operating loss carry-forwards are attributable to stock options, the benefit of which will be credited to additional paid-in capital if realized.  The ultimate realization of these assets is dependent upon the generation of future taxable income sufficient to offset the related deductions and loss carryforwards within the applicable carryforward period.  Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will not be able to realize the benefits of these deductible differences at March 31, 2014.
	ASC 740 provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements.  Tax positions must meet a “more-likely-than-not” recognition threshold before a benefit is recognized in the financial statements.  As of March 31, 2014, the Company has not recorded a liability for uncertain tax positions.  Included in net deferred tax assets is approximately $597,000 of research credits.  While the Company believes that the credit calculations are correct, it is possible that upon an examination by taxing authorities, the research credits available to offset future taxable income may be reduced in whole or in part.  However, as the Company is not currently recognizing a benefit for the research credits, there is no impact to the financial statements pursuant to ASC 740.  There have been no income tax related interest or penalties assessed or recorded and if interest and penalties were to be assessed, the Company would charge interest and penalties to income tax expense.  It is not anticipated that unrecognized tax benefits would significantly increase or decrease within 12 months of the reporting date.  The Company files income tax returns in the U.S. and various state jurisdictions and there are open statutes of limitations for taxing authorities to audit the Company’s tax returns from years ended March 31, 2010 through the current period.

Note_6_Related_Party_Transacti

Note 6 - Related Party Transactions	12 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	Note 6 – Related Party Transactions
	See Note 2 “Notes Payable and Long Term Debt,” and Note 8 “Stockholders’ Equity” to our financial statements for discussion related to debt and equity transactions involving our officers, directors and 5% or greater shareholders.

Note_7_Commitments_and_Conting

Note 7 - Commitments and Contingencies	12 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	Note 7 – Commitments and Contingencies
	We lease an office space in Boulder, Colorado. As of September 30, 2011, the Company executed an amendment to the lease which reduced the square footage and monthly rent and extended the lease term. We lease 9,868 square feet with a current monthly rent of $9,000. We also pay our proportionate share of building taxes, insurance and operating expenses. The term continues until September 30, 2014, unless modified under specified circumstances.  As of April 14, 2014 the lease term was extended to September 30, 2016.  The agreement contains other standard office lease provisions.
	In May 2011, the Company reached an agreement with Wildernest Logistics Solutions to provide warehousing, distribution and fulfillment operations, and seed pod kit manufacturing. The agreement calls for a monthly $10,000 facility charge.  The Company has extended its agreement with Wildernest Logistics Solutions effective April 17, 2014 for a two-year term with automatic one-year renewals.
	Future cash payments under such agreements for the remaining years are as follows:
	Year Ending	Rent
		(in thousands)
	31-Mar-15		236
	31-Mar-16		239
	31-Mar-17		60
		$	535
	Rent expense for the years ended March 31, 2014 and 2013, was $259,000 and $260,000, respectively.

Note_8_Stockholders_Equity

Note 8 - Stockholders' Equity	12 Months Ended
	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	Note 8 – Stockholders’ Equity
	On October 17, 2012, a 1-for-100 reverse stock split of AeroGrow’s common stock became effective.  As a result of the reverse stock split, every 100 shares of AeroGrow’s pre-reverse split common stock were converted automatically into one share of common stock.  All references below to shares of common stock, common stock warrants, or common stock options have been adjusted to reflect the reverse stock split.
	Common Stock and Common Stock Warrants
	As of March 31, 2014, the Company had 6,129,326 common shares issued and outstanding out of the 750,000,000 shares (par value $0.001 per share) that have been authorized by the Company’s shareholders.
	Between May and September 2010, the Company completed a private offering of $7.0 million in 8% Subordinated Secured Convertible Notes due May 6, 2013, 702,000 common stock warrants that were issued to investors, and 140,400 common stock warrants that were issued to the placement agent for the offering.  The Subordinated Secured Convertible Notes had an original conversion price of $1.00 per common share, and could be converted into common shares at any time at the option of the holder.  The conversion price may be adjusted in accordance with customary anti-dilution rights.  In addition, under certain circumstances, the Company can force conversion of the Subordinated Secured Convertible Notes.  Each warrant issued as part of the offering of Subordinated Secured Convertible Notes entitles the holder to purchase one share of the Company's common stock at a price of $20.00 per share, and contains customary anti-dilution rights (for stock splits, stock dividends and sales of substantially all the Company’s assets) and piggyback registration rights.  The warrants issued to the placement agent also contain a cashless exercise provision.  All of the warrants expire May 6, 2015.
	On April 11, 2012, all of the outstanding Subordinated Secured Convertible Notes (including accrued interest) were converted to an aggregate of 2,977,815 common shares pursuant to a restructuring approved by the holders of the Subordinated Secured Convertible Notes and the company’s stockholders.
	On October 28, 2010 and November 5, 2010, the Company closed on the private sale of $1.5 million in 2010 Credit Card Receipts-Backed Notes, whereby 50,000 warrants were issued to investors and 8,334 warrants were issued to the placement agent.  The 2010 Credit Card Receipts-Backed Notes were convertible at the option of the holders into common stock of AeroGrow at a conversion price of $18.00 per share.  The 2010 Credit Card Receipts-Backed Notes were repaid in full on October 3, 2011.  Each warrant issued pursuant to the 2010 Credit Card Receipts-Backed Notes entitles the holder to purchase one share of the Company's common stock at a price of $20.00 per share, and contains customary anti-dilution rights (for stock splits, stock dividends and sales of substantially all the Company’s assets) and piggyback registration rights.  These warrants expire October 28, 2015.
	On May 8, 2012, the Company announced that it would temporarily reduce the exercise price on all outstanding warrants to purchase its common stock (the “Warrants”) to $0.96 per common share, between May 10, 2012 and May 31, 2012 (the “Temporary Exercise Period”).  In the aggregate, 113 warrant holders exercised warrants during the Temporary Exercise Period and the Company issued 1,624,477 shares of common stock.
	During the Temporary Exercise Period, 942,241 Warrants were exercised for cash and the Company issued 942,241 shares of common stock against the exercise of these Warrants.  In addition, during the Temporary Exercise Period a total of 153,743 Warrants were exercised that had a “cashless exercise” provision allowing the holders to use the in-the-money value of the Warrants being exercised to satisfy the full exercise cost of the Warrants (the “Cashless Warrants”).  The Company issued 35,490 shares against the exercise of the Cashless Warrants.
	During the Temporary Exercise Period the Company issued 646,761 new Warrants to holders who acquired their Warrants with the Company’s 8% Subordinated Secured Convertible Promissory Notes and who exercised their existing Warrants during the Temporary Exercise Period (the “Additional Warrants”).  The Additional Warrants had an exercise price of $1.00 per share, and expired on May 31, 2012, if not previously exercised.  All of the Additional Warrants issued were exercised during the Temporary Exercise Period.
	As described in Note 3 above, on April 22, 2013 the Company issued warrants to purchase 125,000 shares of common stock to the placement agent for the Scotts Miracle-Gro Transaction.  This warrant has an exercise price of $1.54 per share (125% of the average closing price of the Company’s common stock during the five-day period prior to the April 22, 2013 closing date).  The value of this warrant was estimated at $108,000, based on the Black-Scholes model with a stock price of $1.30, calculated exercise price of $1.54, expected life of three years, annualized volatility of 117.2% and a discount rate of 0.39%.  The value of the warrant was recorded as stock issuance costs.
	In addition, the Company also issued a warrant to an affiliate of Scotts Miracle-Gro as part of the Scotts Miracle-Gro Transaction (the “Scotts Miracle-Gro Warrant”).  The Scotts Miracle-Gro Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a “fully diluted basis” (as defined in the Securities Purchase Agreement), constitute 80% of the Company’s outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise.  The Scotts Miracle-Gro Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date).  In addition, the Scotts Miracle-Gro Warrant can be exercised in any increment; there is no obligation to exercise the entire Scotts Miracle-Gro Warrant at one time.  For additional details regarding the Scotts Miracle-Gro Warrant, see “Note 3 – Scotts Miracle-Gro Transaction” above.
	A summary of the Company’s common stock warrant activity for the period from April 1, 2012 through March 31, 2014 is presented below:
			Warrants				Weighted
			Outstanding (in thousands)				Average Exercise Price				Aggregate Intrinsic Value
	Outstanding, April 1, 2012			931			$	26.6
	Granted			1,341				4.11
	Exercised			(1,743	)			10.36
	Expired			(1	)			636.62
	Outstanding, March 31, 2013			528			$	22.41			$	-
	Granted			175				1.74
	Exercised			(125	)			1.54
	Expired			(3	)			108.86
	Outstanding, March 31, 2014			575			$	20.24			$	383
	As of March 31, 2014, the Company had the following outstanding warrants to purchase its common stock:
					Weighted Average
	Warrants Outstanding (in thousands)				Exercise Price				Remaining Life (Yrs)
		50			$	2.1				4.52
		394			$	7				3.03
		122			$	20				1.12
		1			$	25				0.52
		7			$	800				0.43
		1			$	825				0.43
		575			$	20.24				2.72
	The tables above exclude the warrant issued to Scotts Miracle-Gro because the warrant is not issuable in any certain number of shares, as discussed above.
	Preferred Stock and Preferred Stock Warrants
	The Company's Articles of Incorporation authorize the issuance of 20,000,000 shares of preferred stock with $0.001 par value.
	Series A Convertible Preferred Stock.  As of March 31, 2014, the Company had no shares of Series A Convertible Preferred Stock (the “Series A Stock”) issued and outstanding.
	As s of March 31, 2012, the Company had 7,526 shares of Series A Shares issued and outstanding. On April 11, 2012, 7,526 shares of Series A Stock were converted into 950,805 shares of the Company’s Common Stock reflecting an effective conversion rate of 126.34 shares of Common Stock per share of Series A Stock. Subsequent to the conversions, there were no shares of Series A Stock outstanding.  The Series A Stock holders agreed to convert the Series A Stock into Common Stock in exchange for the Company agreeing to reduce the effective conversion price and in exchange for the Company issuing warrants to purchase Common Stock (the “Common Stock Warrants”) to the Series A Stock holders.
	A summary of the Company’s Series A Warrant activity for the period from April 1, 2012 through March 31, 2014 is presented below:
			Series A Warrants				Weighted Average
			Outstanding				Exercise Price
	Outstanding, April 1, 2012			4,164			$	1,250
	Granted			-				-
	Exercised			4,164				1,250
	Expired			-				-
	Outstanding, March 31, 2013			-			$	-
	Granted			-				-
	Exercised			-				-
	Expired			-				-
	Outstanding, March 31, 2014			-			$	-
	On April 11, 2012, all outstanding Series A Warrants were converted into an aggregate of 462,680 common warrants with an exercise price of $7.00 per common share and with an expiration date of April 11, 2017.  In addition, the Series A Share holders were issued a dividend consisting of 231,347 warrants to purchase common stock with an exercise price of $7.00 per share and an expiration date of April 11, 2017.
	Series B Convertible Preferred Stock.  As described in Note 3 above, on April 22, 2013 the Company issued 2,649,007 shares of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share to an affiliate of Scotts Miracle-Gro Gro as part of the Scotts Miracle-Gro Transaction.  The Securities Purchase Agreement, Certificates of Designations for the Series B Preferred Stock, Form of Warrant, Indemnification Agreement, Investor’s Rights Agreement and Voting Agreement have been filed as exhibits to a Current Report on Form 8-K that was filed with the SEC on April 23, 2013.  The Series B Preferred Stock is convertible into 2,649,007 shares of common stock ($4.0 million divided by a conversion price of $1.51 per share).  The Series B Convertible Preferred Stock bears a cumulative annual dividend of 8.0%, payable in shares of the Company’s common stock at a conversion price of $1.51 per share (subject to customary anti-dilution rights, as described in the Series B Convertible Preferred Stock Certificates of Designations).  As of March 31, 2014, based on the number of shares issuable to Scotts Miracle-Gro the company has accrued $1.5 million for the stock dividend.  For additional details regarding the Series B Convertible Preferred Stock, see “Note 3 – Scotts Miracle-Gro Transaction” above.

Note_9_Subsequent_Events

Note 9 - Subsequent Events	12 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	Note 9 – Subsequent Events
	None.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)

12 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

'

Use of Estimates, Policy [Policy Text Block]

'

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  It is reasonably possible that a change in the Company’s estimates will occur in the near term and such change could be material.

Earnings Per Share, Policy [Policy Text Block]

'

Net Income (Loss) per Share of Common Stock

The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260.  ASC 260 requires companies with complex capital structures to present basic and diluted Earnings per Share (“EPS”).  Basic EPS is measured as the income or loss available to common shareholders divided by the weighted average shares of common stock outstanding for the period.  Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented.  Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.  For the years ended March 31, 2014 and 2013, the Company had 3.6 million (including preferred stock), and 3.5 million, respectively, of securities that could potentially dilute basic EPS in the future that were not included in the computation of diluted EPS because to do so would have been anti-dilutive for the periods presented.

The following table presents the computation of basic and diluted net income per share for the year ended March 31, 2014 (in thousands, except per share amounts):

Fiscal Year Ended March 31,

2014

2013

Net loss available to common shareholders

$

(4,130

)

(8,259

)

Basic and diluted:

Weighted-average shares outstanding

5,408

5,344

Basic and diluted net loss per share

$

(0.76

)

(1.55

)

As of March 31, 2014, employee stock options to purchase approximately 397,000 shares of common stock  and  warrants to purchase approximately 575,000 shares of common stock were outstanding but were not included in the computation of diluted net income per share because the effect of including such shares would have been anti-dilutive in the periods presented.

Reclassification, Policy [Policy Text Block]

'

Reclassifications

Certain prior year amounts have been reclassified to conform to current year presentation.

Cash and Cash Equivalents, Policy [Policy Text Block]

'

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.  There were no cash equivalents at March 31, 2014 and 2013.

Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]

'

Restricted Cash

The Company has secured activity related to its corporate credit card purchase account with a restricted money market account.  In addition, as discussed in Note 2– Notes Payable and Long Term Debt, 20% of the Company’s daily credit card receipts were held in a restricted escrow account in accordance with the 2011 Credit Card Receipts-Backed Notes which were paid in full during the year ended March 31, 2014.  The balance in this account as of March 31, 2014 and March 31, 2013 was $15,000 and $42,000, respectively.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

'

Concentrations of Risk

ASC 825-10-50-20 requires disclosure of significant concentrations of credit risk regardless of the degree of such risk.  Financial instruments with significant credit risk include cash deposits.  The amount on deposit with one financial institution exceeded the $250,000 federally insured limit as of March 31, 2014.  However, management believes that the financial institution is financially sound and the risk of loss is minimal.

Customers:

For the years ended March 31, 2014 and 2013, the Company had one customer, Amazon.com, who represented 30.7%, and 10.9%, respectively, of the Company’s net revenue.

Suppliers:

For the year ended March 31, 2014, the Company purchased inventories and other inventory related items from four suppliers totaling $1.5 million, $1.4 million, $315,000, and $300,000 representing 26.0%, 24.3%, 5.6% and 5.4% of cost of revenue, respectively.  For the year ended March 31, 2013, the Company purchased inventories and other inventory related items from four suppliers totaling $587,000, $543,000, $469,000, and $360,000 representing 14.6%, 13.5%, 11.7% and 9.0% of cost of revenue, respectively.

The Company’s primary contract manufacturers are located in China.  As a result, the Company may be subject to political, currency, regulatory, shipping, labor and weather/natural disaster risks.  Although the Company believes alternate sources of manufacturing could be obtained, these risks and any potential loss of supply could have an adverse impact on operations.

Account Receivables:

As of March 31, 2014, the Company had three customers, Amazon.com, Costco.com and The Home Depot, that represented 44.1%, 24.5% and 11.1%, respectively, of outstanding accounts receivable.  As of March 31, 2013, the Company had one customer, Amazon.com, that represented 61.2% of outstanding accounts receivable.  Management believes that all receivables from these customers are collectible.

Fair Value of Financial Instruments, Policy [Policy Text Block]

'

Fair Value of Financial Instruments

The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), as it relates to the fair value of its financial assets and liabilities.  This guidance requires disclosure of fair value information about certain financial instruments (insurance contracts, real estate, goodwill and taxes are excluded) for which it is practicable to estimate such values, whether or not these instruments are included in the balance sheet at fair value. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts that could be realized upon immediate liquidation.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability, i.e., exit price, in an orderly transaction between market participants. ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3.  The three levels of the fair value hierarchy are described below:

Level 1:

Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2:

Observable market-based inputs, other than quoted prices in active markets for identical assets or liabilities.

Level 3:

Unobservable inputs.

The carrying value of financial instruments, including cash, receivables, accounts payable and accrued expenses, approximates their fair value at March 31, 2014 and March 31, 2013 due to the relatively short-term nature of these instruments.  As of March 31, 2014 and March 31, 2013, the fair value of the Company's debt, notes payable, and sale of intellectual property liability, using Level 3 inputs was estimated using the discounted cash flow method, which is based on the future expected cash flows, discounted to their present values, using a discount rate of 15%.

In conjunction with a Securities Purchase Agreement and strategic alliance with Scotts Miracle-Gro on April 22, 2013, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock together with existing stock owned.  This warrant was accounted for as a liability at its estimated fair value and is classified as a Level 3 fair value measurement.  The Company calculated the fair value of the warrant during the fiscal year ended March 31, 2014 using Level 3 inputs in a Monte Carlo simulation model.  As of March 31, 2014, the Company measured the warrant at fair value and will continue to do so on a quarterly basis.  As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.

31-Mar-14

31-Mar-13

(in thousands)

Fair Value

Carry Value

Fair Value

Carry Value

Liabilities

Notes payable

$

-

$

-

$

610

$

641

Sale of intellectual property liability

171

258

-

-

Derivative warrant liability

2,530

2,530

-

-

Long-term debt

-

-

1,726

2,068

Total

$

2,701

$

2,788

$

2,336

$

2,709

Property, Plant and Equipment, Policy [Policy Text Block]

'

Property and Equipment

Property and equipment are stated at cost.  Depreciation for financial accounting purposes is computed using the straight-line method over the estimated lives of the respective assets.  Office equipment and computer hardware are depreciated over five years.  Tooling is depreciated over three years. Leasehold improvements are being amortized over the life of the lease.

Property and equipment consist of the following:

March 31,

March 31,

(in thousands)

2014

2013

Manufacturing equipment and tooling

$

2,423

$

2,269

Computer equipment and software

435

406

Leasehold improvements

116

112

Other equipment

348

348

3,322

3,135

Less:  accumulated depreciation

(3,024

)

(2,869

)

Property and equipment, net

$

298

$

266

Depreciation expense for the years ended March 31, 2014 and 2013, was $156,000, and $161,000, respectively.

Intangible Assets, Finite-Lived, Policy [Policy Text Block]

'

Intangible Assets

Intangible assets consist of the direct costs incurred for application fees and legal expenses associated with patents and trademarks on the Company's products.  The Company periodically reviews the value of the intangible assets.  To the extent carrying values exceed estimated fair values, the Company records a reduction in the carrying value to the determined fair value.   The Company amortizes its patent and trademark costs on a straight line basis over their estimated useful life of 17 years.

Intangible assets consist of the following:

March 31,

March 31,

(in thousands)

2014

2013

Patents

$

-

$

286

Trademarks

2

44

2

330

Less:  accumulated amortization

-

(135

)

Intangible assets, net

$

2

$

195

Amortization expense for the years ended March 31, 2014 and 2013, was less than $1,000 and $14,000, respectively.

As of April 22, 2013, the Company agreed to sell to Scotts Miracle-Gro all intellectual property associated with the Company’s hydroponic products, other than the AeroGrow and AeroGarden trademarks, free and clear of all encumbrances, for $500,000.  Scotts Miracle-Gro has the right to use the AeroGrow and AeroGarden trademarks in connection with the sale of products incorporating the Hydroponic IP.

In return, Scotts Miracle-Gro granted the Company an exclusive right to use the Hydroponic intellectual property (“IP”) in North America and certain European countries in return for a royalty of 2% of annual net sales, as determined at the end of each fiscal year.  The royalty is payable in the Company's common stock at the conversion price of the Series B Preferred Stock (see Note 3).  The initial term of the Technology License is five years, and the Company may renew the Technology License for an additional five-year term by providing notice to Scotts Miracle-Gro at least six months in advance of the expiration of each five-year term.  Please see Note 3 “Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions” to our financial statements for further discussion.

Inventory, Policy [Policy Text Block]

'

Inventory

Inventories are valued at the lower of cost, as determined by the first-in, first-out method, or market. Included in inventory where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity.  A majority of the Company’s products are manufactured overseas and are recorded at standard cost.

March 31,

March 31,

(in thousands)

2014

2013

Finished goods

$

784

$

606

Raw materials

527

623

$

1,311

$

1,229

The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product.  As of March 31, 2014 and 2013, the Company had reserved $332,000 and $94,000, respectively, for inventory obsolescence.

Receivables, Policy [Policy Text Block]

'

Accounts Receivable and Allowance for Doubtful Accounts

The Company sells its products to retailers and consumers. Consumer transactions are paid primarily by credit card. Retailer sales terms vary by customer, but are generally net 30 days to net 60 days. Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable.  The Company's allowance estimate is based on a review of the current status of trade accounts receivable.

Other Receivables

In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for required credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor.  This reserve is equal to 5% of the credit card sales processed during the previous six months. As of March 31, 2014 and March 31, 2013, the balance in this reserve account was $187,000 and $169,000, respectively.

Advertising Costs, Policy [Policy Text Block]

'

Advertising and Production Costs

The Company expenses all production costs related to advertising, including, print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed.  The Company records media costs related to its direct-to-consumer advertisements, inclusive of postage and printing costs incurred in conjunction with mailings of direct response catalogues, and related direct response advertising costs, in accordance ASC 340-20-Reporting on Advertising Costs.  As prescribed by ASC 340-20-25, direct-to-consumer advertising costs incurred should be reported as assets and should be amortized over the estimated period of the benefits, based on the proportion of current period revenue from the advertisement to probable future revenue.

As the Company has re-entered the retail distribution channel, the Company has expanded its advertising to online gateway and portal advertising, as well as placement in third party catalogues.

Advertising expenses for the years ended March 31, 2014 and March 31, 2013, were as follows:

Fiscal Year Ended March 31,

2014

2013

(in thousands)

Direct-to-consumer

$

786

$

1,055

Retail

404

1

Total advertising expense

$

1,190

$

1,056

As of March 31, 2014 and March 31, 2013, the Company had deferred $16,000 and $4,000, respectively, related to such media costs.  The costs are included in the prepaid and other expenses line of the balance sheet.

Research and Development Expense, Policy [Policy Text Block]

'

Research and Development

Research, development, and engineering costs are expensed as incurred.  Research, development, and engineering expenses primarily include payroll and headcount related costs, contractor fees, infrastructure costs, and administrative expenses directly related to research and development support.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

'

Stock-Based Compensation

The Company uses the Black-Scholes option valuation model to estimate the fair value of stock option awards.  For the years ended March 31, 2014 and March 31, 2013, equity compensation in the form of stock options and grants of restricted stock that vested totaled $257,000 and $177,000, respectively, and is included in the accompanying Statements of Operations in the following categories:

Years ended

(in thousands)

31-Mar-14

31-Mar-13

General and administrative

$

200

$

136

Sales and marketing

57

41

Total

$

257

$

177

Income Tax, Policy [Policy Text Block]

'

Income Taxes

Deferred income taxes are recognized for the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at the end of each period, based on enacted laws and statutory rates applicable to the periods in which the differences are expected to affect taxable income.  Any liability for actual taxes to taxing authorities is recorded as income tax liability. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.  A valuation allowance is established against such assets where management is unable to conclude that it is “more likely than not” that the value of such asset will be realized.  As of March 31, 2014 and March 31, 2013, the Company recognized a valuation allowance equal to 100% of the net deferred tax asset balance.

Revenue Recognition, Policy [Policy Text Block]

'

Revenue Recognition

The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists: that is, a product is shipped under an agreement with a customer; risk of loss and title has passed to the customer; the fee is fixed or determinable; and collection of the resulting receivable is reasonably assured.

The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions and other volume-based incentives. Certain incentive programs require the Company to estimate based on industry experience the number of customers who will actually redeem the incentive.  At March 31, 2014 and March 31, 2013, the Company had accrued $42,000 and $43,000 respectively, as its estimate for the foregoing deductions and allowances.  These expenses are included in the accrued expenses line of the balance sheet.

Standard Product Warranty, Policy [Policy Text Block]

'

Warranty and Return Reserves

The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program.  The specific warranty terms and conditions vary depending upon the product sold but generally include technical support, repair parts and labor for periods up to one year.  Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation.   Based upon the foregoing, the Company has recorded as of March 31, 2014 and March 31, 2013 a provision for potential future warranty costs of $11,000 and $10,000, respectively.  These warranty expenses are included in the accrued expenses line of the balance sheet.

The Company reserves for known and potential returns and associated refunds or credits related to such returns based upon historical experience. In certain cases, customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments to us by such customers.  As of March 31, 2014 and March 31, 2013, the Company has recorded a reserve for customer returns of $61,000 and $27,000, respectively.  These expenses are included in the accrued expenses line of the balance sheet.

Shipping and Handling Cost, Policy [Policy Text Block]

'

Shipping and Handling Costs

Shipping and handling costs associated with inbound freight are recorded in cost of revenue. Shipping and handling costs associated with freight out to customers are also included in cost of revenue. Shipping and handling charges paid by customers are included in product sales.

Lease, Policy [Policy Text Block]

'

Deferred Rent

In July 2006, the Company entered into a facility lease with a term through January 2012, for its corporate offices in Boulder, Colorado.  As of September 30, 2011 this lease was extended through September 30, 2014.  As of April 14, 2014 the lease term was extended to September 30, 2016.  As of March 31, 2014 and March 31, 2013, the Company had recorded deferred rent related to this agreement in the amount of $3,000 and $6,000, respectively, based on the difference between straight-line rent expense recorded and the rent payment obligation.

Deferred Charges, Policy [Policy Text Block]

'

Deferred Debt Issuance Costs

The Company capitalizes debt issuance costs that are directly attributable to realizing the proceeds of the debt issued and it is amortized over the contractual life of the debt using the effective interest rate method.

Segment Reporting, Policy [Policy Text Block]

'

Segments of an Enterprise and Related Information

GAAP utilizes a management approach based on allocating resources and assessing performance as the source of the Company's reportable segments.  GAAP also requires disclosures about products and services, geographic areas and major customers.  At present, the Company operates in one segment.

New Accounting Pronouncements, Policy [Policy Text Block]

'

New Accounting Pronouncements

In July 2013, the FASB issued ASU 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” which among other things, requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as denoted within the ASU.  The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013.  This new guidance will not have a material impact on our financial statements.

In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers," which amended revenue recognition guidance to clarify the principles for recognizing revenue from contracts with customers.  The guidance requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services.  The guidance also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract.   This accounting guidance is effective for the Company beginning in the first quarter of fiscal year 2018 using one of two prescribed retrospective methods.  Early adoption is not permitted.  We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.

Note_1_Description_of_the_Busi1

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Mar. 31, 2014
Disclosure Text Block [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'The following table presents the computation of basic and diluted net income per share for the year ended March 31, 2014 (in thousands, except per share amounts):
		Fiscal Year Ended March 31,
		2014				2013
	Net loss available to common shareholders		$	(4,130	)		(8,259	)
	Basic and diluted:
	Weighted-average shares outstanding			5,408			5,344
	Basic and diluted net loss per share		$	(0.76	)		(1.55	)
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.
			31-Mar-14						31-Mar-13
	(in thousands)		Fair Value			Carry Value			Fair Value		Carry Value
	Liabilities
	Notes payable		$	-		$	-		$	610	$	641
	Sale of intellectual property liability			171			258			-		-
	Derivative warrant liability			2,530			2,530			-		-
	Long-term debt			-			-			1,726		2,068
	Total		$	2,701		$	2,788		$	2,336	$	2,709
Property, Plant and Equipment [Table Text Block]	'Property and equipment consist of the following:
			March 31,			March 31,
	(in thousands)		2014			2013
	Manufacturing equipment and tooling		$	2,423		$	2,269
	Computer equipment and software			435			406
	Leasehold improvements			116			112
	Other equipment			348			348
				3,322			3,135
	Less:  accumulated depreciation			(3,024	)		(2,869	)
	Property and equipment, net		$	298		$	266
Schedule of Intangible Assets and Goodwill [Table Text Block]	'Intangible assets consist of the following:
			March 31,			March 31,
	(in thousands)		2014			2013
	Patents		$	-		$	286
	Trademarks			2			44
				2			330
	Less:  accumulated amortization			-			(135	)
	Intangible assets, net		$	2		$	195
Schedule of Inventory, Current [Table Text Block]	'Inventories are valued at the lower of cost, as determined by the first-in, first-out method, or market. Included in inventory where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity. A majority of the Company’s products are manufactured overseas and are recorded at standard cost.
			March 31,			March 31,
	(in thousands)		2014			2013
	Finished goods		$	784		$	606
	Raw materials			527			623
			$	1,311		$	1,229
Schedule of Advertising Expenses [Table Text Block]	'Advertising expenses for the years ended March 31, 2014 and March 31, 2013, were as follows:
			Fiscal Year Ended March 31,
			2014			2013
	(in thousands)
	Direct-to-consumer		$	786		$	1,055
	Retail			404			1
	Total advertising expense		$	1,190		$	1,056
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	'The Company uses the Black-Scholes option valuation model to estimate the fair value of stock option awards. For the years ended March 31, 2014 and March 31, 2013, equity compensation in the form of stock options and grants of restricted stock that vested totaled $257,000 and $177,000, respectively, and is included in the accompanying Statements of Operations in the following categories:
			Years ended
	(in thousands)		31-Mar-14			31-Mar-13
	General and administrative		$	200		$	136
	Sales and marketing			57			41
	Total		$	257		$	177

Note_2_Notes_Payable_and_Long_1

Note 2 - Notes Payable and Long Term Debt (Tables)	12 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'We relied upon a variety of debt funding sources to help meet our liquidity requirements during the fiscal years ended March 31, 2014 and 2013, as summarized below:
		March 31,		March 31,
		2014		2013
		(in thousands)		(in thousands)
	Main Power Promissory Note	$	-	$	1,704
	First Western Trust Term Loan		-		323
	Notes Payable –Credit Card Receipts-Backed Notes		-		640
	Pawnee Lease Promissory Note		-		42
	Sale of intellectual property liability (see Note 3)		258		-
	Derivative warrant liability (see Note 3)		2,530		-
	Total debt		2,788		2,709
	Less current portion		2,788		1,540
	Long term debt	$	-	$	1,169

Note_4_Equity_Compensation_Pla1

Note 4 - Equity Compensation Plans (Tables)	12 Months Ended
	Mar. 31, 2014
Share-based Arrangements with Employees and Nonemployees [Abstract]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'A summary of option activity in the 2005 Plan is as follows:
							Exercise price
			Options												Weighted-
			(in thousands)				Low				High				Average
	Balances at April 1, 2012			106			$	7			$	20			$	9.5
	Granted			266				1.01				1.01				1.01
	Exercised			-				-				-				-
	Forfeited			(92	)			1.01				12				1.39
	Balances at March 31, 2013			280				1.01				20				4.11
	Granted			331				1.1				2.42				1.89
	Exercised			(100	)			1.01				2.2				1.09
	Forfeited			(114	)			1.01				20				5.08
	Balances at March 31, 2014			397			$	1.01			$	13			$	1.63
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]	'Information regarding all stock options outstanding under the 2005 Plan as of March 31, 2014 is as follows:
					OPTIONS OUTSTANDING														OPTIONS EXERCISABLE
									Weighted-												Weighted-
									average								Aggregate				average		Weighted-		Aggregate
									Remaining				Weighted-				Intrinsic				Remaining		average		Intrinsic
	Exercise price				Options (in thousands)				Contractual Life (years)				Exercise Price				Value (in thousands)		Options (in thousands)		Contractual Life (years)		Exercise Price		Value (in thousands)
	$	1.01				106				3.86			$	1.01						38		3.86	$	1.01
	$	1.1				60				4			$	1.1						60		4	$	1.1
	$	1.21				50				4			$	1.21						50		4	$	1.21
	$	2.2				169				4.41			$	2.2						51		4.16	$	2.2
	$	2.42				10				4.52			$	2.42						5		4.52	$	2.42
	$	7				-				0.27			$	7						-		0.27	$	7
	$	12				1				0.44			$	12						1		0.44	$	12
	$	13				1				0.36			$	13						1		0.36	$	13
						397				4.14			$	1.63			$	2,260		206		4	$	1.49	$	1,206

Note_5_Income_Taxes_Tables

Note 5 - Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	'Income tax provision consisted of the following:
	Income tax provision consisted of the following:
	(in thousands)
		For the Years Ended March 31,
		2014			2013
	Current:
	Federal	$	-		$	-
	Foreign
	State		2			1
			2			1
	Deferred:
	Federal		-			-
	Foreign		-			-
	State		-			-
			-			-
	Income tax provision	$	2		$	1
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'Reconciliation of effective tax rate:
	Reconciliation of effective tax rate:
		For the Years Ended March 31,
		2014			2013
	Federal taxes at statutory rate		34	%		34	%
	State taxes, net of federal benefit		0.21	%		1.18	%
	Permanent items		-31.27	%		-15	%
	Change in effective tax rate		9.02	%		-4.14	%
	Prior year adjustment to book income		0	%		0	%
	Other Adjustments		-0.8	%		0.14	%
	Valuation allowance		-8.85	%		-16.19	%
	Stock-based compensation		-2.36	%		0	%
	Effective income tax rate		-0.05	%		-0.02	%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'Deferred tax assets:
	(in thousands)	As of March 31,
		2014			2013
	Deferred tax assets:
	Net Operating Loss	$	21,885		$	21,566
	R & D credit carryforwards		597			603
	Intangibles and fixed assets		152			110
	Accrued compensation		20			3
	Allowance for bad debt		2			-
	Reserve for customer returns		22			10
	Warranty reserve		4			3
	Reserve for obsolete inventory		122			34
	Stock-compensation		1,412			1,483
	Charitable contributions		2			3
	Other		34			76
	Gross deferred tax assets		24,252			23,891
	Deferred tax liabilities:
	Prepaid expenses		(64	)		(44	)
	Gross deferred tax liabilities		(64	)		(44	)
	Net deferred tax assets before valuation allowance		24,188			23,847
	Valuation allowance		(24,188	)		(23,847	)
	Deferred tax assets (liabilities), net	$	-		$	-

Note_7_Commitments_and_Conting1

Note 7 - Commitments and Contingencies (Tables)	12 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	'Future cash payments under such agreements for the remaining years are as follows:
	Year Ending	Rent
		(in thousands)
	31-Mar-15		236
	31-Mar-16		239
	31-Mar-17		60
		$	535

Note_8_Stockholders_Equity_Tab

Note 8 - Stockholders' Equity (Tables)	12 Months Ended
	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'A summary of the Company’s common stock warrant activity for the period from April 1, 2012 through March 31, 2014 is presented below:
			Warrants				Weighted
			Outstanding (in thousands)				Average Exercise Price				Aggregate Intrinsic Value
	Outstanding, April 1, 2012			931			$	26.6
	Granted			1,341				4.11
	Exercised			(1,743	)			10.36
	Expired			(1	)			636.62
	Outstanding, March 31, 2013			528			$	22.41			$	-
	Granted			175				1.74
	Exercised			(125	)			1.54
	Expired			(3	)			108.86
	Outstanding, March 31, 2014			575			$	20.24			$	383
Schedule of Stockholders Equity [Table Text Block]	'As of March 31, 2014, the Company had the following outstanding warrants to purchase its common stock:
					Weighted Average
	Warrants Outstanding (in thousands)				Exercise Price				Remaining Life (Yrs)
		50			$	2.1				4.52
		394			$	7				3.03
		122			$	20				1.12
		1			$	25				0.52
		7			$	800				0.43
		1			$	825				0.43
		575			$	20.24				2.72
Schedule of preferred stock warrant activity [Table Text Block]	'A summary of the Company’s Series A Warrant activity for the period from April 1, 2012 through March 31, 2014 is presented below:
			Series A Warrants				Weighted Average
			Outstanding				Exercise Price
	Outstanding, April 1, 2012			4,164			$	1,250
	Granted			-				-
	Exercised			4,164				1,250
	Expired			-				-
	Outstanding, March 31, 2013			-			$	-
	Granted			-				-
	Exercised			-				-
	Expired			-				-
	Outstanding, March 31, 2014			-			$	-

Note_1_Description_of_the_Busi2

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Net Income (Loss) Attributable to Parent	($2,406,000)	($8,259,000)
Retained Earnings (Accumulated Deficit)	-80,134,000	-76,004,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	3,600,000	3,500,000
Cash Equivalents, at Carrying Value	0	0
Restricted Cash and Cash Equivalents, Current	15,000	42,000
Number of Financial Institutions in Excess of FDIC Insured Amounts	1	'
Cash, FDIC Insured Amount	250,000	'
Fair Value Inputs, Discount Rate	15.00%	'
Depreciation	156,000	161,000
Amortization of Intangible Assets	1,000	14,000
Other receivable, reserve percentage of credit card sales	5.00%	'
Other Receivables, Net, Current	187,000	169,000
Deferred Advertising Costs	16,000	4,000
Employee Benefits and Share-based Compensation	257,000	177,000
Other Accrued Liabilities	42,000	43,000
Provision for Future Warranty Costs	11,000	10,000
Return reserve allowance, percentage	'1% to 2% range	'
Deferred Rent Credit	3,000	6,000
Number of Operating Segments	1	'
Major Supplier 1 [Member] | Cost of Goods, Total [Member] | Supplier Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	26.00%	14.60%
Cost of Goods Sold	1,500,000	587,000
Major Supplier 2 [Member] | Cost of Goods, Total [Member] | Supplier Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	24.30%	13.50%
Cost of Goods Sold	1,400,000	543,000
Major Supplier 3 [Member] | Cost of Goods, Total [Member] | Supplier Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	5.60%	11.70%
Cost of Goods Sold	315,000	469,000
Major Supplier 4 [Member] | Cost of Goods, Total [Member] | Supplier Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	5.40%	9.00%
Cost of Goods Sold	300,000	360,000
Office Equipment [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Property, Plant and Equipment, Useful Life	'5 years	'
Tooling [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Property, Plant and Equipment, Useful Life	'3 years	'
Employee Stock Option [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	397,000	'
Warrant [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	'	575,000
Major customer 1 [Member] | Accounts Receivable [Member] | Credit Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	44.10%	61.20%
Major customer 2 [Member] | Accounts Receivable [Member] | Credit Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	24.50%	'
Major customer 3 [Member] | Accounts Receivable [Member] | Credit Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	11.10%	'
Inventory Valuation Reserve [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Inventory Valuation Reserves	332,000	94,000
Allowance for Sales Returns [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Inventory Valuation Reserves	$61,000	$27,000
Patents [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Finite-Lived Intangible Asset, Useful Life	'17 years	'
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Customer	'one customer	'one customer
Concentration Risk, Percentage	30.70%	10.90%
Cost of Goods, Total [Member] | Supplier Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Supplier	'four suppliers	'four suppliers
Accounts Receivable [Member] | Credit Concentration Risk [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'
Concentration Risk, Customer	'three customers	'one customer

Note_1_Description_of_the_Busi3

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share, Basic and Diluted (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Schedule of Earnings Per Share, Basic and Diluted [Abstract]	'	'
Net loss available to common shareholders	($4,130)	($8,259)
Basic and diluted:	'	'
Weighted-average shares outstanding	5,408	5,344
Basic and diluted net loss per share	($0.76)	($1.55)

Note_1_Description_of_the_Busi4

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Liabilities	'	'
Sale of intellectual property liability	$258	$0
Derivative warrant liability	2,530	0
Total	2,788	2,709
Estimate of Fair Value Measurement [Member]	'	'
Liabilities	'	'
Notes payable	0	610
Sale of intellectual property liability	171	0
Derivative warrant liability	2,530	0
Long-term debt	0	1,726
Total	2,701	2,336
Reported Value Measurement [Member]	'	'
Liabilities	'	'
Notes payable	0	641
Sale of intellectual property liability	258	0
Derivative warrant liability	2,530	0
Long-term debt	0	2,068
Total	$2,788	$2,709

Note_1_Description_of_the_Busi5

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Property, Plant and Equipment (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$3,322	$3,135
Less: accumulated depreciation	-3,024	-2,869
Property and equipment, net	298	266
Machinery and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	2,423	2,269
Computer Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	435	406
Leasehold Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	116	112
Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$348	$348

Note_1_Description_of_the_Busi6

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Intangible Assets and Goodwill (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Intangible Assets and Goodwill [Line Items]	'	'
Intangible assets, gross	$2	$330
Less: accumulated amortization	0	-135
Intangible assets, net	2	195
Patents [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Intangible Assets and Goodwill [Line Items]	'	'
Intangible assets, gross	'	286
Trademarks [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Intangible Assets and Goodwill [Line Items]	'	'
Intangible assets, gross	$2	$44

Note_1_Description_of_the_Busi7

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Inventory (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Schedule of Inventory [Abstract]	'	'
Finished goods	$784	$606
Raw materials	527	623
	$1,311	$1,229

Note_1_Description_of_the_Busi8

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Advertising Expenses (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Advertising Expenses [Line Items]	'	'
Advertising expense	$1,190	$1,056
Direct-to-consumer [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Advertising Expenses [Line Items]	'	'
Advertising expense	786	1,055
Retail [Member]	'	'
Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Advertising Expenses [Line Items]	'	'
Advertising expense	$404	$1

Note_1_Description_of_the_Busi9

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details) - Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'
General and administrative	$1,634	$1,818
Sales and marketing	2,920	2,325
Total	257	177
Share-based Compensation [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'
General and administrative	200	136
Sales and marketing	$57	$41

Note_2_Notes_Payable_and_Long_2

Note 2 - Notes Payable and Long Term Debt (Details) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2010

Mar. 31, 2012

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2011

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2011

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Mar. 31, 2012

Mar. 31, 2014

Directors and Officers [Member]

Non-Officer and Non-Director Investors with more than 5% Ownership [Member]

Accrued Interest Converted [Member]

Main Power Promissory Note [Member]

Main Power Promissory Note [Member]

Revised Main Power Note [Member]

Revised Main Power Note [Member]

First Western Trust Term Loan [Member]

First Western Trust Term Loan [Member]

Subordinated Secured Convertible Notes [Member]

Subordinated Secured Convertible Notes [Member]

Subordinated Secured Convertible Notes [Member]

Subordinated Secured Convertible Notes [Member]

2011 Credit card receipts-backed notes [Member]

2011 Credit card receipts-backed notes [Member]

2011 Credit card receipts-backed notes [Member]

2011 Credit Card Offering [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

Pawnee Promissory Note [Member]

Liability Associated with Scotts Miracle-Gro Transaction [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

Subordinated Secured Convertible Notes [Member]

Debt Conversion Costs on the Exchange [Member]

Accelerated Recognition of the Debt Discount and Deferred Debt Issuance Costs [Member]

Shares Issued to Placement Agents as Additional Compensation [Member]

Note 2 - Notes Payable and Long Term Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

$245,000

$350,000

'

'

$1,400,000

'

'

'

$1,000,000

'

'

'

$7,000,000

'

'

$1,600,000

'

'

'

$1,300,000

'

$116,000

'

Debt Instrument, Payment Terms

'

'

'

'

'

'

'

'monthly interest payments through the final maturity and principal payments totaling $159,000 during Fiscal 2013, $555,000 during the fiscal year ending March 31, 2014, $725,000 during the fiscal year ending March 31, 2015, and $665,000 during the period April 2015 through December 2015.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal in Year Two

'

'

'

'

'

'

'

159,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal in Year Three

'

'

'

'

'

'

'

'

555,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal in Year Four

'

'

'

'

'

'

'

'

725,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal in Year Five

'

'

'

'

'

'

'

'

665,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of Debt

'

'

'

'

'

950,000

'

'

'

'

'

'

'

'

'

'

198,000

'

'

'

'

'

'

'

'

Gains (Losses) on Extinguishment of Debt

489,000

0

'

'

'

489,000

'

'

'

'

'

3,400,000

3,200,000

6,600,000

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Maturity Date, Description

'

'

'

'

'

'

'

'

'

'

'four-year loan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

7.25%

'

'

'

'

'

'

17.00%

'

'

'

15.00%

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

'

'

'

'

'

21-May-14

'

'

'

'

'

'

'

'

'

'

'

31-Jan-14

'

'

Debt Instrument, Description

'

'

'

'

'

'

'

'

'

'as of March 21, 2014, we repaid the FWTB Loan in full including the principal balance and all accrued interest

'

'

'

'

'

'

'As of September 13, 2012, the Company repaid the remaining principal balance and accrued interest on the 2011 Credit Card Notes in full.

'

'

'

'on December 17, 2013, the Company repaid the 2012 Credit Card Notes in full, including the principal balance and accrued interest

'

'

'

'

Class of Warrant or Rights, Granted (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

70,200

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Original Debt, Amount

'

'

'

'

648,000

'

'

'

'

'

'

'

'

7,400,000

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

2,977,815

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

$2.50

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Terms of Conversion Feature

'

'

'

'

'

'

'

'

'

'

'

'

'

'The Subordinated Secured Convertible Note holders agreed to convert the Subordinated Secured Convertible Notes into common stock in exchange for our agreement to reduce the conversion price from $10.00 per share of common stock to $2.50 per share of common stock.

'

'

'

'

'

'

'

'

'

'

'

Convertible Notes Payable

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Collateral

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'backed by a portion of our prospective credit card receipts, (the "2011 Credit Card Notes") and a 1% share of our prospective monthly sales into the network marketing channel for a period of three years following our first sale into the network marketing channel

'

'

'

'

'20% of our daily credit card receipts were held in escrow with First Western Trust Bank under an Escrow and Account Control Agreement to fund bi-weekly payments of principal and interest to the investors in the 2012 Credit Card Offering

'

'

Debt, consideration

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'consisted of $1.5 million in cash and the conversion of $156,000 in other obligations of the Company, including $61,000 of deferred compensation owed to executive officers of AeroGrow

'

'

'

'comprised $1.3 million in cash

'

'

'

Debt Issuance Cost

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

47,000

'

'

'

47,000

'

'

'

Proceeds from Debt, Net of Issuance Costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,400,000

'

'

'

1,200,000

'

'

'

Debt Instrument, Debt Issuance Costs, Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'In addition, the Company paid a deferred sales commission to the placement agent equal to 10% of the MLM Revenue Share paid to investors in the 2011 Credit Card Offering (with the deferred sales commission reduced to 6% for payments to company-referred investors and 0% on payments to officers and directors), concurrently with the payment of the MLM Revenue Share.

'

'

'

'$47,000 of placement agent sales commissions (5% on third-party investors, 3% on company-referred investors and 0% on investments by our officers and directors) and expenses, net cash proceeds to AeroGrow totaled $1.2 million.

'

'

'

Debt, deferred sales commissions, percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

'

'

'

'

'

'

Debt, deferred sales commissions, Company referred-investors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

'

'

'

'

'

'

'

Debt, deferred sales commission, officers and directors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.00%

'

'

'

'

'

'

'

Amortization of Deferred Charges

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

218,000

'

23,000

24,000

'

'

'

Stock Issued During Period, Shares, Other (in Shares)

'

'

24,500

35,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,858

'

128,573

'

'

'

Debt, sales commission percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

'

'

'

Debt, sales commission, percentage, Company referred investors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

'

'

'

Debt, sales commission percentage officers and directors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.00%

'

'

'

Shares Issuance, Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'one share of common stock for every 10 shares issued to investors

'

'

'

'

'

Debt Instrument, Interest Rate Terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'The Lease Promissory Note carried an interest rate of 6% per annum for the first twelve months, and 8% per annum thereafter.

'

Derivative Asset, Fair Value, Gross Liability

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,500,000

Debt, Current

$258,000

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$258,000

Note_2_Notes_Payable_and_Long_3

Note 2 - Notes Payable and Long Term Debt (Details) - Schedule of Debt (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Schedule of Debt [Abstract]	'	'
Main Power Promissory Note	$0	$1,704
First Western Trust Term Loan	0	323
Notes Payable –Credit Card Receipts-Backed Notes	0	640
Pawnee Lease Promissory Note	0	42
Sale of intellectual property liability (see Note 3)	258	0
Derivative warrant liability (see Note 3)	2,530	0
Total debt	2,788	2,709
Less current portion	2,788	1,540
Long term debt	$0	$1,169

Note_3_Scotts_MiracleGro_Trans1

Note 3 - Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) (USD $)

12 Months Ended

12 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Apr. 23, 2013

Mar. 31, 2014

Mar. 31, 2014

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Technology Licensing Agreement [Member]

Brand License Agreement [Member]

Supply Chain Service Agreement [Member]

Main Power Promissory Note [Member]

Main Power Promissory Note [Member]

Scotts Miracle-Gro Company [Member]

Placement Agent Warrants for Security Purchase Agreement [Member]

Main Power Promissory Note [Member]

Securities Purchase Agreement with SMG Growing Media, Inc. [Member]

Securities Purchase Agreement with SMG Growing Media, Inc. [Member]

Note 3 - Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

2,649,007

2,649,007

'

'

'

'

'

'

'

Shares Issued, Price Per Share

'

'

'

$0.00

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, New Issues

$4,000,000

'

'

$4,000,000

'

'

'

'

'

'

'

'

Proceeds from Issuance of Convertible Preferred Stock

'

'

'

3,800,000

'

'

'

'

'

'

'

'

Repayments of Debt

'

'

950,000

'

'

'

'

'

950,000

'

'

'

Inventory Held on Consignment

'

'

'

'

'

'

'

'

'

237,000

'

'

Class of Warrant or Rights, Granted

'

'

'

'

'

'

'

'

'

'

'

125,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

'

'

'

'

'

'

'

'

'

'

'

$1.54

Class of Warrant or Rights, Exercise Price, Description

'

'

'

'

'

'

'

'

'

'

'

'125% of the average closing price of the Company's common stock during the five-day period prior to the April 22, 2013 closing date

Fair Value Adjustment of Warrants

'

'

'

'

'

'

'

'

'

'

'

108,000

Share Price

'

'

'

'

'

'

'

'

'

'

'

$1.30

Fair Value Assumptions, Expected Term

'

'

'

'

'

'

'

'

'

'

'

'3 years

Fair Value Assumptions, Expected Volatility Rate

'

'

'

'

'

'

'

'

'

'

'

117.20%

Fair Value Inputs, Discount Rate

15.00%

'

'

'

'

'

'

'

'

'

'

0.39%

Convertible Preferred Stock, Shares Issued upon Conversion

'

'

'

2,649,007

'

'

'

'

'

'

'

'

Preferred Stock, Conversion Basis

'

'

'

'$4.0 million divided by a conversion price of $1.51 per share

'$4.0 million divided by a conversion price of $1.51 per share

'

'

'

'

'

'

'

Preferred Stock, Dividend Rate, Percentage

'

'

'

8.00%

8.00%

'

'

'

'

'

'

'

Preferred Stock, Dividend Payment Terms

'

'

'

'payable in shares of the Company's common stock at a conversion price of $1.51 per share

'payable in shares of the Company's common stock at a conversion price of $1.51 per share

'

'

'

'

'

'

'

Convertible Preferred Stock, Terms of Conversion

'

'

'

'(i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Preferred Stock own 50.1% of the issued and then-outstanding common stock of the Company, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Preferred Stock and such exercise of the Warrant

'

'

'

'

'

'

'

'

Warrant, Description of Warrants

'

'

'

'The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a "fully diluted basis" (as defined in the Securities Purchase Agreement), constitute 80% of the Company's outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise. The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date). In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time. The exercise price of the Warrant shall be equal to the quotient obtained by dividing:(a) an amount equal to (i) 1.34 times the trailing twelve months "Net Sales" (which includes sales of the Company's products by Scotts Miracle-Gro and its affiliates) minus (ii) "Debt Outstanding" net of cash (as such terms are defined in the Warrant,by(b) the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.

'

'

'

'

'

'

'

'

Derivative Liability, Fair Value, Gross Liability

'

'

'

2,500,000

'

'

'

'

'

'

'

'

Proceeds from Sale of Intangible Assets

500,000

0

'

'

'

'

'

'

'

'

500,000

'

Debt, Current

258,000

0

'

'

'

'

'

'

'

'

258,000

'

Royalty Description

'

'

'

'

'

'2% of annual net sales (the "Royalty"), as determined at the end of each fiscal year

'amount equal to 5% of incremental growth in annual net sales, as compared to net sales during the fiscal year ended March 31, 2013

'

'

'

'

'

Accrued Liabilities, Current

$306,000

$292,000

'

'

'

$187,000

'

'

'

'

'

'

Licensing Term

'

'

'

'

'

'The initial term of the Technology License is five years, and the Company may renew the Technology License for an additional five-year terms by providing notice to Scotts Miracle-Gro at least six months in advance of the expiration of each five-year term, provided that Scotts Miracle-Gro is not in default under the Technology Licensing Agreement at the time of renewal. The Technology License may not be assigned.

'The initial term of the brand license will be five years, and the Company may renew the license for additional five-year terms by providing notice to Scotts Miracle-Gro at least six months in advance of the expiration of each five-year term, provided that Scotts Miracle-Gro is not in default under the brand license at the time of renewal.

'

'

'

'

'

License Payment Terms

'

'

'

'

'

'

'payable in the Company's common stock at $1.51 per share

'

'

'

'

'

Service Agreement Description

'

'

'

'

'

'

'

'Scotts Miracle-Gro will pay the Company an annual fee equal to 7% of the cost of goods of all products that Scotts Miracle-Gro purchases from the Company or a vendor, in exploiting the hydroponic IP internationally (outside of the Company Markets) over the course of each contract year during the term of the Securities Purchase Agreement

'

'

'

'

Note_4_Equity_Compensation_Pla2

Note 4 - Equity Compensation Plans (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2010	Mar. 31, 2009	Mar. 31, 2006
Note 4 - Equity Compensation Plans (Details) [Line Items]	'	'	'	'	'	'
Stockholders' Equity, Reverse Stock Split	'	'1-for-100	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)	397,000	'	'	'	'	'
Employee Benefits and Share-based Compensation (in Dollars)	$257,000	$177,000	'	'	'	'
Options Granted February 8, 2013 [Member] | Equity Compensation Plan (2005 Plan) [Member]	'	'	'	'	'	'
Note 4 - Equity Compensation Plans (Details) [Line Items]	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	'	0.00%	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	'	116.06%	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	'	0.40%	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'	'3 years	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	'	$0.69	'	'	'	'
Options Granted April 1, 2013 [Member] | Equity Compensation Plan (2005 Plan) [Member]	'	'	'	'	'	'
Note 4 - Equity Compensation Plans (Details) [Line Items]	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	'	0.00%	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	'	117.21%	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	'	0.39%	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'	'3 years	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	'	$0.76	'	'	'	'
Options Granted October 9, 2013 [Member] | Equity Compensation Plan (2005 Plan) [Member]	'	'	'	'	'	'
Note 4 - Equity Compensation Plans (Details) [Line Items]	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	'	0.00%	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	'	3.00%	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	'	0.62%	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate	'	118.29%	'	'	'	'
Equity Compensation Plan (2005 Plan) [Member]	'	'	'	'	'	'
Note 4 - Equity Compensation Plans (Details) [Line Items]	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)	'	13,505,000	'	'	'	1,505,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in Shares)	'	'	'	10,000,000	2,000,000	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in Dollars per share)	$1.01	'	$1.01	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in Dollars per share)	$13	'	$20	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	331,000	266,000	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)	397,000	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	'	$1.53	'	'	'	'
Employee Benefits and Share-based Compensation (in Dollars)	257,000	177,000	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares (in Shares)	'	191,000	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	'	$235,000	'	'	'	'
Minimum [Member]	'	'	'	'	'	'
Note 4 - Equity Compensation Plans (Details) [Line Items]	'	'	'	'	'	'
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price (in Dollars per share)	$1.10	$1.01	'	'	'	'
Maximum [Member]	'	'	'	'	'	'
Note 4 - Equity Compensation Plans (Details) [Line Items]	'	'	'	'	'	'
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price (in Dollars per share)	$2.42	$1.01	'	'	'	'

Note_4_Equity_Compensation_Pla3

Note 4 - Equity Compensation Plans (Details) - Schedule of Share-based Compensation, Stock Options, Activity (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Note 4 - Equity Compensation Plans (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]	'	'
Balances (in Shares)	397,000	'
Balances	1.63	'
Number of Shares [Member]	'	'
Note 4 - Equity Compensation Plans (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]	'	'
Balances (in Shares)	280,000	106,000
Granted (in Shares)	331,000	266,000
Exercised (in Shares)	-100,000	0
Forfeited (in Shares)	-114,000	-92,000
Balances (in Shares)	397,000	280,000
Weighted average exercise price [Member]	'	'
Note 4 - Equity Compensation Plans (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]	'	'
Balances	4.11	9.5
Granted	1.89	1.01
Exercised	1.09	0
Forfeited	5.08	1.39
Balances	1.63	4.11
Minimum [Member]	'	'
Note 4 - Equity Compensation Plans (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]	'	'
Balances	1.01	7
Granted	1.1	1.01
Exercised	1.01	0
Forfeited	1.01	1.01
Balances	1.01	1.01
Maximum [Member]	'	'
Note 4 - Equity Compensation Plans (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]	'	'
Balances	20	20
Granted	2.42	1.01
Exercised	2.2	0
Forfeited	20	12
Balances	13	20

Note_4_Equity_Compensation_Pla4

Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable (USD $)	12 Months Ended
	Mar. 31, 2014
Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
OPTIONS OUTSTANDING - Options (in Shares)	397,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 51 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.63
OPTIONS OUTSTANDING - Aggregate Intrinsic Value (in Dollars)	$2,260,000
OPTIONS EXERCISABLE - Options (in Shares)	206,000
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.49
OPTIONS EXERCISABLE - Aggregate Intrinsic Value (in Dollars)	1,206,000
Options Exercise Price $1.01 [Member]	'
Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$1.01
OPTIONS OUTSTANDING - Options (in Shares)	106,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'3 years 313 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.01
OPTIONS EXERCISABLE - Options (in Shares)	38,000
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'3 years 313 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.01
Options Exercise Price $1.10 [Member]	'
Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$1.10
OPTIONS OUTSTANDING - Options (in Shares)	60,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.10
OPTIONS EXERCISABLE - Options (in Shares)	60,000
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.10
Options Exercise Price $1.21 [Member]	'
Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$1.21
OPTIONS OUTSTANDING - Options (in Shares)	50,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.21
OPTIONS EXERCISABLE - Options (in Shares)	50,000
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.21
Options Exercise Price $2.20 [Member]	'
Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$2.20
OPTIONS OUTSTANDING - Options (in Shares)	169,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 149 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$2.20
OPTIONS EXERCISABLE - Options (in Shares)	51,000
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 58 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$2.20
Options Exercise Price $2.42 [Member]	'
Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$2.42
OPTIONS OUTSTANDING - Options (in Shares)	10,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 189 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$2.42
OPTIONS EXERCISABLE - Options (in Shares)	5,000
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 189 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$2.42
Options Exercise Price $7.00 [Member]	'
Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$7
OPTIONS OUTSTANDING - Options (in Shares)	'
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'98 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$7
OPTIONS OUTSTANDING - Aggregate Intrinsic Value (in Dollars)	'
OPTIONS EXERCISABLE - Options (in Shares)	'
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'98 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$7
OPTIONS EXERCISABLE - Aggregate Intrinsic Value (in Dollars)	'
Options Exercise Price $12.00 [Member]	'
Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$12
OPTIONS OUTSTANDING - Options (in Shares)	1,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'160 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$12
OPTIONS OUTSTANDING - Aggregate Intrinsic Value (in Dollars)	'
OPTIONS EXERCISABLE - Options (in Shares)	1,000
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'160 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$12
OPTIONS EXERCISABLE - Aggregate Intrinsic Value (in Dollars)	'
Options Exercise Price $13.00 [Member]	'
Note 4 - Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$13
OPTIONS OUTSTANDING - Options (in Shares)	1,000
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'131 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$13
OPTIONS OUTSTANDING - Aggregate Intrinsic Value (in Dollars)	'
OPTIONS EXERCISABLE - Options (in Shares)	1,000
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'131 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$13
OPTIONS EXERCISABLE - Aggregate Intrinsic Value (in Dollars)	'

Note_5_Income_Taxes_Details

Note 5 - Income Taxes (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Note 5 - Income Taxes (Details) [Line Items]	'	'
Operating Loss Carryforwards	$60,200,000	$60,300,000
Operating Loss Carryforwards, Expiration Date	'2034	'
Attributable to Stock Options [Member]	'	'
Note 5 - Income Taxes (Details) [Line Items]	'	'
Operating Loss Carryforwards	$546,000	'

Note_5_Income_Taxes_Details_Sc

Note 5 - Income Taxes (Details) - Schedule of Components of Income Tax Expense (Benefit) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Current:	'	'
Federal	$0	$0
Foreign	0	0
State	2	1
	2	1
Deferred:	'	'
Federal	0	0
Foreign	0	0
State	0	0
	0	0
Income tax provision	$2	$1

Note_5_Income_Taxes_Details_Sc1

Note 5 - Income Taxes (Details) - Schedule of Effective Income Tax Rate Reconciliation	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Schedule of Effective Income Tax Rate Reconciliation [Abstract]	'	'
Federal taxes at statutory rate	34.00%	34.00%
State taxes, net of federal benefit	0.21%	1.18%
Permanent items	-31.27%	-15.00%
Change in effective tax rate	9.02%	-4.14%
Prior year adjustment to book income	0.00%	0.00%
Other Adjustments	-0.80%	0.14%
Valuation allowance	-8.85%	-16.19%
Stock-based compensation	-2.36%	0.00%
Effective income tax rate	-0.05%	-0.02%

Note_5_Income_Taxes_Details_Sc2

Note 5 - Income Taxes (Details) - Schedule of Deferred Tax Assets and Liabilities (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Deferred tax assets:	'	'
Net Operating Loss	$21,885	$21,566
R & D credit carryforwards	597	603
Intangibles and fixed assets	152	110
Accrued compensation	20	3
Allowance for bad debt	2	0
Reserve for customer returns	22	10
Warranty reserve	4	3
Reserve for obsolete inventory	122	34
Stock-compensation	1,412	1,483
Charitable contributions	2	3
Other	34	76
Gross deferred tax assets	24,252	23,891
Deferred tax liabilities:	'	'
Prepaid expenses	-64	-44
Gross deferred tax liabilities	-64	-44
Net deferred tax assets before valuation allowance	24,188	23,847
Valuation allowance	-24,188	-23,847
Deferred tax assets (liabilities), net	$0	$0

Note_7_Commitments_and_Conting2

Note 7 - Commitments and Contingencies (Details) (USD $)	12 Months Ended		0 Months Ended	12 Months Ended	0 Months Ended	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Apr. 14, 2014	Mar. 31, 2014	Apr. 17, 2014	Mar. 31, 2014
			Office space [Member]	Office space [Member]	Warehousing, distribution and fulfillment facility [Member]	Warehousing, distribution and fulfillment facility [Member]
			Subsequent Event [Member]	sqft	Subsequent Event [Member]
Note 7 - Commitments and Contingencies (Details) [Line Items]	'	'	'	'	'	'
Area of Real Estate Property (in Square Feet)	'	'	'	9,868	'	'
Operating Leases, Rent Expense, Minimum Rentals	'	'	'	$9,000	'	$10,000
Description of Lessee Leasing Arrangements, Operating Leases	'	'	'As of April 14, 2014 the lease term was extended to September 30, 2016.	'	'The Company has extended its agreement with Wildernest Logistics Solutions effective April 17, 2014 for a two-year term with automatic one-year renewals.	'
Operating Leases, Rent Expense	$259,000	$260,000	'	'	'	'

Note_7_Commitments_and_Conting3

Note 7 - Commitments and Contingencies (Details) - Schedule of Future Minimum Rental Payments for Operating Leases (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified
Schedule of Future Minimum Rental Payments for Operating Leases [Abstract]	'
31-Mar-15	$236
31-Mar-16	239
31-Mar-17	60
	$535

Note_8_Stockholders_Equity_Det

Note 8 - Stockholders' Equity (Details) (USD $)

12 Months Ended

12 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2011

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2011

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Issued to placement agent [Member]

Issued to placement agent [Member]

Series A Warrant [Member]

Series A Warrant [Member]

Private Placement May to September 2010 [Member]

Private Placement May to September 2010 [Member]

Private Placement October 28, 2010 and November 5, 2010 [Member]

Temporary Exercise Period [Member]

Warrants exercised during Temporary Exercise Period [Member]

Warrants exercised during Temporary Exercise Period that had cashless exercise provision [Member]

Scotts Miracle-Gro Company [Member]

Private Placement May to September 2010 [Member]

Private Placement October 28, 2010 and November 5, 2010 [Member]

Conversion of Warrants [Member]

Note 8 - Stockholders' Equity (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders' Equity, Reverse Stock Split

'

'1-for-100

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued

6,129,326

5,904,877

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Outstanding

6,129,326

5,904,877

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares Authorized

750,000,000

750,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Par or Stated Value Per Share (in Dollars per share)

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Convertible Debt (in Dollars)

'

'

'

'

'

'

'

'

'

'

$7,000,000

$1,500,000

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

8.00%

'

'

'

'

'

Class of Warrant or Rights, Granted

'

'

'

'

'

140,400

8,334

'

'

'

702,000

50,000

646,761

'

'

125,000

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

$1

$18

'

'

'

'

Preferred Stock, Dividend Payment Terms

'

'

'

'

'payable in shares of the Company's common stock at a conversion price of $1.51 per share

'

'

'

'

'issued as part of the offering of Subordinated Secured Convertible Notes entitles the holder to purchase one share of the Company's common stock at a price of $20.00 per share, and contains customary anti-dilution rights (for stock splits, stock dividends and sales of substantially all the Company's assets) and

'

'

'

'

'

'

Stock Issued During Period, Shares, Conversion of Convertible Securities

'

2,977,815

'

'

'

'

'

'

'

'

'

'

1,624,477

942,241

35,490

'

Class of Warrant or Right, Number of Securities Called by Each Warrant or Right

'

'

'

'

'

'

'

'

'

'

'

1

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

'

'

'

'

'

'

'

$7

$7

'

'

$20

$0.96

'

'

$1.54

Convertible Preferred Stock, Shares Issuable Upon Conversion

'

'

'

'

'

'

'

'

'

'

'

'

113

'

'

'

Class of Warrant or Rights, Exercised

'

'

'

'

'

'

'

'

'

'

'

'

'

942,241

153,743

'

Class of Warrant or Rights, Exercise Price, Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'125% of the average closing price of the Company's common stock during the five-day period prior to the April 22, 2013 closing date

Fair Value Adjustment of Warrants (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$108,000

Share Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.30

Fair Value Assumptions, Exercise Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.54

Fair Value Assumptions, Expected Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'3 years

Fair Value Assumptions, Expected Volatility Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

117.20%

Fair Value Inputs, Discount Rate

15.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.39%

Warrant, Description of Warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'In addition, the Company also issued a warrant to an affiliate of Scotts Miracle-Gro as part of the Scotts Miracle-Gro Transaction (the "Scotts Miracle-Gro Warrant"). The Scotts Miracle-Gro Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a "fully diluted basis" (as defined in the Securities Purchase Agreement), constitute 80% of the Company's outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise. The Scotts Miracle-Gro Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date). In addition, the Scotts Miracle-Gro Warrant can be exercised in any increment; there is no obligation to exercise the entire Scotts Miracle-Gro Warrant at one time

Equity Method Investment, Ownership Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

80.00%

Preferred Stock, Shares Authorized

20,000,000

20,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Par or Stated Value Per Share (in Dollars per share)

$0.00

$0.00

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Issued

2,649,007

0

'

7,526

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Outstanding

2,649,007

0

'

7,526

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of Stock, Shares Issued

'

'

950,805

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Conversion Basis

'

'

'effective conversion rate of 126.34 shares of Common Stock per share of Series A Stock

'

'$4.0 million divided by a conversion price of $1.51 per share

'

'

'

'

'

'

'

'

'

'

'

Class of Warrants or Rights, Conversion of Preferred Warrants to Common Warrants

'

'

'

'

'

'

'

462,680

'

'

'

'

'

'

'

'

Common Stock Dividends, Shares

'

'

'

'

'

'

'

'

231,347

'

'

'

'

'

'

'

Investment Warrants Expiration Date

'

'

'

'

'

'

'

'

11-Apr-17

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

2,649,007

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Dividend Rate, Percentage

'

'

'

'

8.00%

'

'

'

'

'

'

'

'

'

'

'

Note_8_Stockholders_Equity_Det1

Note 8 - Stockholders' Equity (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights (USD $)	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
		Warrants outstanding [Member]	Warrants outstanding [Member]	Weighted average exercise price [Member]	Weighted average exercise price [Member]	Aggregate Intrinsic Value [Member]	Aggregate Intrinsic Value [Member]	Aggregate Intrinsic Value [Member]
Class of Warrant or Right [Line Items]	'	'	'	'	'	'	'	'
Outstanding	575,000	528	931	'	'	'	'	'
Outstanding	$20.24	'	'	$22.41	$26.60	'	'	'
Outstanding	$2,260,000	'	'	'	'	$383	$0	$0
Granted	'	175	1,341	'	'	'	'	'
Granted	'	'	'	$1.74	$4.11	'	'	'
Exercised	'	-125	-1,743	'	'	'	'	'
Exercised	'	'	'	$1.54	$10.36	'	'	'
Expired	'	-3	-1	'	'	'	'	'
Expired	'	'	'	$108.86	$636.62	'	'	'
Outstanding	575,000	575	528	'	'	'	'	'
Outstanding	$20.24	'	'	$20.24	$22.41	'	'	'
Outstanding	$2,260,000	'	'	'	'	$383	$0	$0

Note_8_Stockholders_Equity_Det2

Note 8 - Stockholders' Equity (Details) - Schedule of Warrants Outstanding (USD $)	12 Months Ended
	Mar. 31, 2014
Note 8 - Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	575,000
Weighted Average Exercise Price	$20.24
Weighted Average Remaing Life (Yrs)	'2 years 262 days
Warrants Exercisable at $2.10 [Member]	'
Note 8 - Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	50,000
Weighted Average Exercise Price	$2.10
Weighted Average Remaing Life (Yrs)	'4 years 189 days
Warrants Exercisable at $7.00 [Member]	'
Note 8 - Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	394,000
Weighted Average Exercise Price	$7
Weighted Average Remaing Life (Yrs)	'3 years 10 days
Warrants exercisable at $20.00 [Member]	'
Note 8 - Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	122,000
Weighted Average Exercise Price	$20
Weighted Average Remaing Life (Yrs)	'1 year 43 days
Warrants Exercisable at $25.00 [Member]	'
Note 8 - Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	1,000
Weighted Average Exercise Price	$25
Weighted Average Remaing Life (Yrs)	'189 days
Warrants exercisable at $800.00 [Member]	'
Note 8 - Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	7,000
Weighted Average Exercise Price	$800
Weighted Average Remaing Life (Yrs)	'156 days
Warrants exercisable at $825.00 [Member]	'
Note 8 - Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	1,000
Weighted Average Exercise Price	$825
Weighted Average Remaing Life (Yrs)	'156 days

Note_8_Stockholders_Equity_Det3

Note 8 - Stockholders' Equity (Details) - Schedule of Preferred Stock Warrant Activity (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Note 8 - Stockholders' Equity (Details) - Schedule of Preferred Stock Warrant Activity [Line Items]	'	'
Outstanding	575,000	'
Outstanding	20.24	'
Preferred stock warrant [Member] | Warrants outstanding [Member]	'	'
Note 8 - Stockholders' Equity (Details) - Schedule of Preferred Stock Warrant Activity [Line Items]	'	'
Outstanding	0	4,164
Granted	0	0
Exercised	0	4,164
Expired	0	0
Outstanding	0	0
Preferred stock warrant [Member] | Weighted average exercise price [Member]	'	'
Note 8 - Stockholders' Equity (Details) - Schedule of Preferred Stock Warrant Activity [Line Items]	'	'
Outstanding	0	1,250
Granted	0	0
Exercised	0	1,250
Expired	0	0
Outstanding	0	0